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Background: Living with HIV entails navigating complex structural, interpersonal, and 
intrapersonal realities within the healthcare system, peer and family relationships, and the 
community that can affect one’s psychosocial wellbeing. Disclosure of one’s HIV status can 
engender social support, but negative reactions to disclosure can contribute to stigma and poor 
mental health. These psychosocial aspects of living with HIV impact HIV treatment and overall 
wellbeing and require further scientific exploration with individuals throughout the life course to 
inform interventions in contexts where HIV is prevalent, especially sub-Saharan Africa.  
Methods: In Chapter Three, we provide a scoping review of the relationship between mental 
health and the HIV Care Continuum for adolescents living with HIV in sub-Saharan Africa. In 
Chapter Four, we characterize patterns of self-disclosure among adolescents living with HIV in 
Uganda and assess how choices of to whom to disclose are associated with depression and 
anxiety symptoms. In Chapter Five, we qualitatively explore gossip as a means of labeling 
people as living with HIV and as a form of HIV stigma in Botswana.  
Results: We found that adolescents living with HIV were assessed for mental health along the 
HIV Care Continuum disproportionately and primarily only at the “Engaged or Retained in 
Care” step. Adolescents living with HIV in Uganda chose to self-disclose their HIV status to 
their nuclear family members more often than to extended family or peers. This choice to self-
disclose to nuclear family members was mostly associated with non-significant marginally fewer 
depression and anxiety symptoms compared to adolescents who did not self-disclose to these 
individuals. HIV gossip in Botswana was gendered and related to the cultural expectations of 
women and men in Setswana culture. Gossip removed one’s choice to self-disclose their HIV 
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status, and both fear of gossip and experiencing gossip could lead to non-adherent behaviors to 
HIV treatment protocols.  
Conclusion: Further understanding of the experience of HIV through a biopsychosocial 
approach to inform resources and services that promote coping with living with HIV and 
strengthening social support for people living with HIV is necessary to improve quality of life 
and end the epidemic. 
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Chapter 1: Introduction 
1.1 Problem Statement  
In 2014, the Joint United Nations Programme on the Human Immunodeficiency 
Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) (UNAIDS) established the 90-90-90 
Goals outlining an ambitious set of targets to be achieved in the fight to end the AIDS epidemic: 
90% of all people living with HIV (PLHIV) would know their HIV status; 90% of all people 
diagnosed with HIV would be receiving sustained HIV antiretroviral therapy (ART); and, 90% 
of those on ART would be virally suppressed by 2020 (1,2). In accordance with these goals, the 
intention was to make concerted efforts to reach key populations at high risk for HIV/AIDS, 
including sex workers, men who have sex with men, people who inject drugs, and adolescents. 
At the time this agenda was set, overall global AIDS-related deaths had decreased by 35%, while 
deaths among adolescents had risen by 50% (2).  
Adolescents, young individuals ages 10-19 (3), remain a hard to reach population (4,5) 
among whom HIV infections continue to drive the epidemic globally. Pooled estimates from 
2016 compiled to assess progress in reaching the 90-90-90 targets for adolescents across three 
sub-Saharan African (SSA) countries, Malawi, Zambia, and Zimbabwe, demonstrated that less 
then 50% of adolescents living with HIV/AIDS (ALWH) were aware of their HIV status; 
approximately 80% of diagnosed ALWH were on ART; and only 79% of ALWH on ART were 
virally suppressed (6). Comparatively, in these same countries, 78% of adults living with HIV 
knew their status; 90% of diagnosed adults were on ART; and 90% of adults on ART were 
virally suppressed (7).  
Now that the deadline for the 90-90-90 Goals have passed, focus on meeting new 95-95-
95 Goals by 2030 necessitate increased attention to ALWH, who were originally categorized as 
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part of the “missing 10-10-10”, i.e., the 10% of people that were deemed unlikely to be reached 
in pursuit of the original UNAIDS goals preventing reaching 100% (8). Studies suggest that 
primary healthcare providers are not testing for HIV among adolescents as much as they need to, 
and that there is a lack of appropriately developmentally targeted testing services resulting in 
adolescents not knowing their status (9,10) and severely limiting progress towards 95% of 
PLHIV knowing their status (5,11). Delayed identification and referral to treatment can lead 
ALWH to present with worse HIV prognosis complicated by comorbidities (12). Prevalent 
challenges experienced by adolescents in need of HIV care include a scarcity of youth friendly 
services in SSA, limited guidelines for providers on how to implement tailored care for them, 
and conflict between staff and youth stemming from ineffective communication about the 
various challenges ALWH are facing (13). There is also a paucity of consideration as to the 
myriad challenges during the developmental period that may create unique challenges to 
ensuring ALWH receive adequate HIV care to achieve viral suppression (14–16). For instance, 
as emerging adults, HIV infected adolescents must contend with the transition to adult HIV care, 
a time during which they are vulnerable to being lost to care (17).  
To help build the evidence needed to inform public health interventions that address this 
gap and facilitate progress towards ending the HIV epidemic, this dissertation serves to assess 
psychosocial aspects of living with HIV, including stigma and discrimination, across two life 
course stages: adolescence and adulthood. This research seeks to understand some of the most 
pervasive challenges that remain for both adolescents and adults living with HIV, with a focus on 
SSA, as it is the epicenter of the AIDS epidemic (18,19). By examining under-researched 
psychosocial factors associated with worse HIV prognosis in two life course stages, the findings 
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from each of the aims elucidate the need for a shift from the biomedical to a biopsychosocial 
approach to HIV that also incorporates targeted developmental approaches.  
1.2 Background and Significance  
The HIV/AIDS Epidemic in sub-Saharan Africa 
HIV/AIDS is recognized as one of the most harmful and enduring public health threats in 
recent history (18,20). Currently, an estimated 38 million people are living with HIV, of which 
approximately 36 million are adults and 2 million are children under the age of 15. In 2019, there 
were 1.7 million new infections globally and 690,000 people died from AIDS related illnesses 
(21). These figures represent a 40% reduction in annual new HIV infections and a 60% decrease 
in AIDS-related deaths since their peak in 1998 and 2004 (21,22), respectively. The advent of 
multiple efficacious treatment and preventative approaches have fundamentally altered the virus’ 
impact and are largely responsible for observed declines. In particular, antiretroviral therapy 
(ART), pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP) have created 
myriad pathways for reducing the risk of contracting HIV and treating the virus (23). The 
success of ART has extended the lives of PLHIV and has led to HIV now being considered a 
manageable chronic illness (24,25). The accessibility of ART, PrEP and PEP continues to 
increase (26,27), and efforts to educate and inform communities about the importance and 
necessity of using these services to save lives have become widespread (28).  
The impact of the epidemic and progress in its control have varied by population and 
geography. Of the 38 million people living with HIV worldwide (22), SSA bears a 
disproportionate burden, with over 25 million PLHIV residing there (29). While there is a 
generalized epidemic in many SSA settings (30), certain populations are more affected by HIV. 
In particular, adolescent and young adult women in SSA account for 25% of new global HIV 
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infections and are twice as likely to be living with HIV as compared to young men in SSA. 
Cultural conceptions about HIV also lead to the disease being attributed in many cases to poor 
morality, sexuality, and contamination, generating stigma and discrimination that act as key 
barriers to PLHIV seeking treatment in SSA (31). Further, an estimated 40% of PLHIV in SSA 
are unaware of their status, and access to ART is inconsistent across the region, remaining highly 
constrained for many. For instance, in Eastern and Southern Africa, where 20.7 million people 
are living with HIV, over one quarter of adults and more than 40% of children living with HIV 
are still not receiving ART (32). While prevalence is lower in West and Central Africa (where 
only 5 million people are living with HIV), more than one third of PLHIV are estimated to not 
know their status in this region, and rates of ART usage are even lower than in other SSA 
regions (61% for adults and 33% for children) (33).  
Broadening the Biomedical Approach to HIV/AIDS Epidemic Control 
While biomedical advancements for HIV have been, and continue to be, fundamental in 
reducing the global impact of the virus (34), these advancements as described have not fully 
addressed the myriad factors associated with HIV (35). Broadly, biomedical models define 
disease as fully stemming from biological factors, without consideration for psychosocial 
elements of illness; if something cannot be verified on a cellular or molecular level, it tends to be 
less valued or even ignored within healthcare (36). The biomedical model also concedes to a 
“mind-body dualism,” in which the mental and somatic are separate entities (37,38).  
In contrast, the biopsychosocial model is credited with placing importance on the 
individual experience of HIV-related illness and how this subjective experience influences 
diagnosis, treatment, and quality of life (38,39). George Engel conceptualized the 
biopsychosocial model to provide a framework for clinicians to have a better sense of patients 
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experiences with illness, with the argument that a more holistic approach to care would lead to 
better overall health outcomes (38). Applying a biopsychosocial lens illuminates how 
consideration of the psychosocial experience of living with an illness can improve the public 
health response. UNAIDS and the World Health Organization (WHO) are increasingly calling 
for initiatives to provide support for PLHIV to navigate disclosure (40), mental health, and 
stigma, as they help drive the spread of HIV in SSA, and as such, limit what a biological or 
biomedial approaches alone can achieve (41,42). Each of these factors- disclosure, stigma, and 
mental health- and their importance to controlling the HIV/AIDS epidemic, is conceptualized in 
the following sections for the purposes of this dissertation.  
Disclosure. HIV testing and counselling are the first steps in engagement with the 
healthcare system for HIV and the catalyst for PLHIV navigating life with the virus. While 
testing and counselling are integral to linking PLHIV to care and thus saving lives, there are 
negative outcomes that can stem from HIV testing. For example, the disclosure of an individual’s 
HIV status by health care workers (HCWs) without their consent is a frequent occurrence in 
many settings in SSA (43,44). The place where individuals expect to get care for HIV can be a 
harmful setting given the potential for HCWs to disclose one’s status and for community 
members to see individuals at a clinic and to also disclose to others without a PLHIV’s consent 
(45).  
The importance of disclosure as a psychosocial factor to address to achieve better 
individual and population level HIV outcomes can therefore not be understated. Intentional 
disclosure is imperative in obtaining social support to cope with HIV and in the reduction of HIV 
transmission (46,47), via facilitation of informed decision making, e.g., about use of HIV 
prevention methods during sex (48). As legislation that criminilizes non-disclosure in SSA 
 
 6 
becomes prevalent, a precedent is being set that situates the act of disclosure as something to be 
regulated versus a process that can lead to positive outcomes for PLHIV (32,49).  
Stigma and Discrimination. An underrecognized goal set forth in conjunction with both 
the 90-90-90 and 95-95-95 Goals was that of achieving zero discrimination for PLHIV (2). 
Progress towards achieving zero discrimination will be necessary to make progress with both 
adolescents and adults to meet the 95-95-95 goals. HIV discrimination broadly is conceptualized 
to include stigma, denial of care, and violence against PLHIV 5/24/21 10:09:00 PM. Perceived, 
anticipated, enacted, and internalized stigma are all key risk factors for the onset of mental health 
conditions for PLHIV as well (53,54). The added complexity of stigma is that of the culturally 
specific ways it can operate depending on settings. Yet understanding of HIV stigma and its 
cultural nuances in SSA is limited in approaches to inform evidence-based stigma interventions 
that are appropriate for various populations living with HIV (55). 
 The literature on HIV discrimination is extensive and demonstrates that, across the life 
course, PLHIV are susceptible to multiple forms of discrimination which can fundamentally 
change an individual’s ability to cope with an HIV diagnosis (56,57). Stigma, rejection from 
others, and abuse derived from actions including seeking clinical care, being seen taking 
medication, and changes in physical appearance, position PLHIV in highly vulnerable positions 
(58–60). HIV discrimination in all forms has been found to result in diminished ART adherence, 
substance use, higher risk for mental health and neurological disorders, and increased mortality 
5/24/21 10:09:00 PM. For instance, it has been found in numerous settings in SSA, such as 
Botswana and Uganda for example, that PLHIV will seek treatment far from their homes due to 
the associated stigma with being seen receiving care (62–64)5/24/21 10:09:00 PM. Therefore, an 
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HIV diagnosis can be a major life event that sets off a series of life changes that lead to 
discrimination and diminished social support (62,65)5/24/21 10:09:00 PM.  
Furthermore, ALWH who may have begun facing discrimination from a young age may 
have diminished social support by the time they are transitioning to adulthood and are 
responsible for navigating their own healthcare (66,67). It is therefore imperative to address 
discrimination experienced across the life course as a means to improve resources for the 
psychosocial wellbeing of PLHIV and ultimately to make progress in epidemic control. Yet for 
both adolescents and adults, notable reviews have emphasized the limited support structures in 
place for PLHIV to resist discrimination (68) and that the complexity of stigma and 
discrimination experienced by PLHIV exacerbates the inadequacy of the public health response 
to date (69,70). 
Mental disorders. Mental health conditions (i.e. depression, anxiety, PTSD) are some of 
the most common co-morbidities for PLHIV in SSA, and an even larger treatment gap exists for 
mental health conditions than it does for HIV in SSA. Mental disorders experienced by people 
living with HIV have been found to lead to declines in CD4 counts, faster progression to AIDS, 
delayed ART initiation, and poor ART adherence (71,72). ALWH are especially susceptible to 
psychosocial distress, depression, and anxiety from a developmental perspective as having a 
strong social network and being accepted by peers is fundamental in developing a sense of self 
and self-worth as they become adults (73–76).  
Interrelationship of Psychosocial Factors. Disclosure, stigma, and mental health in SSA 
are highly interrelated (77,78). Both HIV stigma and poor mental health are known barriers to 
HIV status disclosure (56,78). Disclosure of one’s HIV status, whether intentional or inadvertent, 
can lead to subsequent stigma towards PLHIV, which places them at increased risk for poor 
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mental health outcomes (57,79). Studies have found that individuals may even question the value 
of knowing their HIV status given the subsequent stigma and stressors that can emerge as a result 
of being HIV positive (65,80). Social isolation, a prevalent result of HIV stigma throughout 
various settings in SSA (81,82), is a known contributor to the onset of poor mental health as 
isolation affects one’s self-esteem and self-worth. 
The interrelationship between these key psyschosocial factors has been specifically 
demonstrated throughout SSA countries. In Botswana, a country with one of the higest 
prevalences of HIV in the world and the first SSA country to provide universal access to HIV 
treatment (83), some individuls have reported believing that mental health conditions stem from 
the inabiliy to accept one’s HIV status and gossip from others about their status (84). Fear of 
stigma itself has been shown to be a critical deterent of ART adherence in Botswana, as well 
(85). Similiarly in Uganda, a country that has made ample strides in providing access to ART 
and that since 2004 provides free access to treatment, the implications of disclosure remains a 
challenge. Common reasons for non-disclosure in Uganda are fear of rejection and causing stress 
within one’s social network (86). Stigma and disclosure continue to be critical barriers to 
treatment adherence for PLHIV in Uganda (87), and are key correlates attributed to poor mental 
health (88).  
1.3 Specific Aims  
  The purpose of this research is to examine under-characterized psychosocial aspects of 
the HIV/AIDS epidemic: disclosure, stigma and mental health. The research broadly explores 
how these psychosocial aspects inform the experience of living with HIV within two different 
life course stages and the ways in which HIV treatment models can be better tailored to address 
them within these developmental periods. Models for HIV care must address the social dynamics 
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of living with HIV. Integral to addressing these dynamics is understanding the experiences and 
decision making around disclosure of HIV/AIDS status as a critical event and its intersection 
with stigma and mental health. Therefore, the larger goal of this research is to inform more 
effective HIV/AIDS care by fostering understanding of disclosure, stigma and mental health in 
SSA with implications for both psychosocial support and HIV treatment in regard to both 
adolescence and adulthood. The first two aims address existing gaps in the adolescent literature 
while the third aim addresses the salient challenge of stigma for adults living with HIV. Specific 
aims include: 
Aim 1: To Conduct a scoping review that examines the relationships between mental 
health and the HIV Care Continuum for ALWH in SSA. This review will include all studies 
assessing the mental health of ALWH in SSA in relationship to engagement among all steps of 
the HIV Care Continuum.  
Aim 2:  To Characterize patterns of disclosure and their relationship to mental health 
among ALWH in Uganda. A descriptive analysis will examine adolescents’ choices around 
disclosure and how these choices are related to depression and anxiety symptoms.  
Aim 3: To qualitatively assess how gossip eliminates the choice to self-disclose one’s 
HIV status among adults living with HIV in Botswana. Gossip will be explored as a form of HIV 
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Chapter 2: Literature Review 
This dissertation specifically focuses on three psychosocial aspects of HIV within SSA:  
disclosure, stigma and mental health. The purpose of this chapter is to demonstrate the relevant 
literature that informs the subsequent aims and questions they explore. A critical element in 
presenting a broad overview of this literature is to also emphasize the difference in terms of the 
existing evidence that speaks to these psychosocial factors among adult PLHIV compared to 
ALWH. We present evidence in this chapter from various settings in SSA to provide a sense of 
the broad landscape of addressing HIV in this setting, with specific examples from Botswana and 
Uganda as they are the settings for chapters 4 and 5.  
2.1 Disclosure  
For the purposes of this dissertation, disclosure of HIV status refers to: “self-disclosure”, 
i.e., when an individual decides whether, when, and how to reveal their HIV status to others; and, 
to instances in which someone else reveals another individual's status with or without that 
person’s consent (e.g., via gossip)(1,2). The contexts in which a PLHIV chooses to reveal their 
status varies greatly across demographics and culture. Estimates of HIV status disclosure within 
SSA are highly variable ranging from 16%-86% of PLHIV having disclosed to anyone across 
regions and countries (3). Men and women living in urban areas are more likely to self-disclose 
than those living in rural areas. In addition, both men and women describe a desire to gain social 
support as a key motivation for disclosing their HIV status (1).  
Self-Disclosure 
Research on disclosure practices in SSA has disproportionately focused on women (4), 
who have been found to be more likely to disclose their status than males living with HIV (5). 
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HIV testing during antenatal care creates a dynamic in which women are often the first to learn 
their status within a relationship, which results in the onus of disclosure falling more commonly 
on them as compared to men (6,7). Variation has been demonstrated across different SSA 
settings, however, with men being found to be more likely to disclose than women in some 
studies (8).  
Predictors of non-disclosure of HIV status among adults are well known in the literature: 
stigma, rejection, the inability to marry, and limited economic opportunities are all documented 
impediments (9–11). Further, being single, having a lower education status, and not having a 
dedicated support group were found to be correlates of non-disclosure in studies in Nigeria and 
Mozambique (12,13). Challenges with navigating safe sexual practices, the inability to accept 
one’s HIV status, and desire for acceptance are also common reasons. Subsequent relationship 
conflicts, fear of violence, and enacted intimate partner violence are prevalent outcomes of 
disclosure that are also often not addressed through HIV treatment and services as found in 
settings such as Nigeria, South Africa, and Zimbabwe (14–16).  
Significantly less research has been conducted on self-disclosure by ALWH as compared 
to adults (17,18). The World Health Organization recommends counselling and support for 
ALWH on self-disclosure, but only a limited number of studies have evaluated the effectiveness 
of these programs in SSA (18,19). The predominant focus of literature on disclosure with ALWH 
focuses on if, when, and how caregivers discloe to a child or adolescent that they are living with 
HIV (20). Of the few studies that examine self-disclosure by an ALWH of their HIV status, 18% 
of ALWH (n=582) were found to have disclosed to a friend, classmate, or partner in a study from 
Uganda and Kenya (21); 67% to family compared to 43% to non-family members (n=97) in a 
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second study from Kenya (22); and over half disclosed only to their immediate family in a study 
of ALWH from South Africa (n=29) (23).  
Disclosure of HIV Status by Others 
Inadvertent disclosure is a common experience for PLHIV that is feared and descried to 
generate subsequent stigma from community members (24–26). Disclosure without one’s 
consent by HCWs is a well-studied phenomenon throughout the continent (1,27). It is also well 
documented that many HCWs believe it is their right to know whether a patient is living with 
HIV and that they can refuse treatment to PLHIV (28). Studies from Ethiopia and Tanzania 
demonstrate the differential treatment of clinicians towards PLHIV in clinical settings including 
not providing care and the practice of testing and disclosing one’s HIV status without consent 
(28,29). In some countries there is even momentum to have mandatory premarital HIV testing 
and to allow health care workers to disclose the results with or without consent to the other party 
(1).  
2.2 Benefits and Limitations of Disclosure 
 
Currently, debate exists as to whether disclosure of HIV status should be as promoted as 
it currently (30). There are scarce programs and resources to aid PLHIV in this process, placing 
undue burden on them to navigate disclosure alone. One critique of the promotion of disclosure 
is that, in the absence of other programs and supports, it does not account for the negative 
outcomes that may result for PLHIV. Particularly in SSA, ample literature demonstrates mixed 
results of disclosing one’s status (30,31). This scarcity of programming remains against the 
backdrop of global recognition (e.g., by organizations such as UNAIDS, WHO, and UNICEF) of 
the need for and benefits of HIV status disclosure (32,33). At the structural level, multiple 
countries within SSA criminalize sex work; same-sex relationships,; and HIV exposure, non-
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disclosure and transmission (34). Some of the most marginalized individuals in SSA are 
therefore placed at increased risk for legal consequences given their identities or behaviors being 
commonly associated with high rates of HIV (35). Often these laws are broad in scope which 
only exacerbates numerous ways to punish PLHIV whether they disclosed their status 
themselves or not (34,36).  
Another reason that supportive disclosure programs are needed is that there has been an 
increase in early initiation to ART. Early initiation has been found to lead to increases in 
disclosure and social support as PLHIV seek adherence support (37) and the ability to openly 
take medications (38,39). The counselling that coincides with ART initiation, including hopeful 
messaging about adherence to ART lowering risk for transmission and increasing one’s ability to 
lead a healthy life (40), is widely credited with increasing self-disclosure. However, early 
initiation may therefore also create pressure on PLHIV to disclose without proper support and 
resources, especially in the absence of healthcare provider training to support PLHIV in the 
longer term (21).  
A main challenge with improving programs to support disclosure is that there is a lack of 
knowledge on what key individuals a PLHIV may want or need to disclose to (22). A majority of 
studies on disclosure from countries in SSA focus exclusively on disclosure to one’s sexual 
partners (5,41,42). Fewer studies focus on disclosing to other parities, such as family members. 
In South Africa, community support initiatives such as counselling from community health 
workers was found to lead to increased disclosure to families. Yet, who PLHIV specifically 
disclosed to in their families was only categorized as being either one’s parents or other family 
members(43) . A similar phenomenon was also observed in a study from Mozambique that did 
not characterize which family members PLHIV were specifically disclosing their HIV status to 
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when they chose to disclose within the family (44). Limited emphasis on support for disclosing 
to the parties different communities of PLHIV want and feel the need to disclose to may 
undermine public health HIV prevention initiatives to promote disclosure. Ultimately, PLHIV 
may be more willing and efficacious in disclosing their HIV status if support is provided for 
disclosing to all individuals who are seen as essential sources of support.  
2.3 Disclosure of HIV Status in Botswana  
 
 Botswana is one of many countries with laws that criminalize the transmission, non-
disclosure or exposure of another to HIV (45). The recent Public Health Act is considered to be a 
violation of the rights of PLHIV (46) given three stipulations that lawfully allow HCWs to 
disclose a patient’s HIV status: 1) to a sexual partner or caregiver if the PLHIV has not disclosed 
after a reasonable amount of time, 2) after the death of a PLHIV, and 3) when disclosing to other 
HCWs involved with treating a PLHIV. Mandatory HIV testing is also allowed if an individual is 
unconscious and unable to give consent, a clinician deems it in the interest of the patient, and 
before any dental or surgical procedure. This law positions PLHIV to be vulnerable to their 
status being disclosed without their consent (47).  
 Ample support is needed in order to increase HIV status disclosure in Botswana (48), as 
perceived stigma and disclosure without one’s consent have been found to hinder this process for 
PLHIV. Acceptance of gender norms that women should be subservient and have less decision-
making power even in matters of sexual and reproductive health also promotes non-disclosure to 
maintain relationships. Further, one study in Botswana also found that clinic staff actively did 
not encourage self-disclosure given the potential outcome of stigma for PLHIV (49). While 
anxiety, rejection from partners, and general fear of reprisal from others have been found to lead 
to limited disclosure in Botswana, reasons for disclosure include the desire to protect others from 
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HIV, getting financial support (50), and being able to have positive social support when it comes 
to HIV treatment (49). Few studies in Botswana specifically examine disclosure among ALWH. 
Of those that do, the focus is on the impact of disclosure to adolescents that they are HIV 
positive 5/24/21 10:09:00 PM.  
2.4 Disclosure of HIV status in Uganda  
 
 The transmission and non-disclosure of HIV is also criminalized in Uganda. Vague 
definitions of intentional and attempted transmission allow courts to assume defendants living 
with HIV in court cases are at fault (36). There were also mandates included in Uganda’s HIV 
and AIDS Prevention and Control Act that allow the disclosure of one’s HIV status without their 
consent to: 1) a guardian if a minor is being treated; 2) HCWs involved in treatment; 3) anyone 
who had exposure to the bodily fluids of a person who was tested for HIV; and, 4) individuals 
with whom the PLHIV comes into close contact.  
Common reasons for non-disclosure in Uganda include being in a relationship for less 
than a year, having lost a family member to AIDS, and diminished social support from others 
who already knew of one’s HIV status (53–55). Pregnant women have also reported challenges 
of disclosure given economic dependence on men, the potential for experiencing violence, and 
being blamed for the spread of HIV within their family (56). Yet, there are also various studies 
demonstrating critical reasons why PLHIV choose to disclose in Uganda. Initiating ART, 
receiving counselling, and seeing role models who have disclosed publicly are all key factors 
associated with self-disclosure (57). Furthermore, with HIV as a risk factor for IPV in Uganda, 
there are efforts to provide more counselling and resources for disclosing HIV in ways that 




Few studies have focused on self-disclosure among ALWH in Uganda. Among the 
studies that exist, there are mixed results in which self disclosure has been associated social 
support, with self-disclosure leading both social support and rejection (21,59). Of additional 
importance are studies with HCWs and caregivers of ALWH who express the need for more 
programmatic support and training to aid ALWH in self-disclosure (60). 
2.5 Stigma  
 
Stigma is an especially salient challenge for PLHIV Studies characterizing predictors of 
internalized stigma and programs to address this type of stigma in SSA are limited (61,62). There 
are mixed results as to what demographics are predictive of internalized stigma as both being 
older and younger have been found to be related to internalized stigma (63), as well as being a 
woman or man (64), and having either higher or lower education. While studies on ART 
adherence are inconsistent in terms of whether this leads to internalized stigma, challenges with 
HIV-related illness and poor treatment outcomes were confirmed predictors of stigma in settings 
including Uganda, Malawi, South Africa, and Tanzania (65,66). In addition, depression has been 
found to lead to internalized stigma in Kenya and Uganda (67,68), as well as to alcohol use in 
South Africa (42).  
As disclosure is a demonstrated catalyst for stigma, various studies convey gossip 
following disclosure and subsequent discrimination as a common form of stigmatizing behavior. 
Anticipated stigma commonly stems from fear of gossip and challenges with navigating sexual 
behavior (69). In addition, avoidance of voluntary counselling and testing may derive from 
anticipated stigma given a positive result, including fear of being treated like a pariah and being 
ousted from social networks (70).  
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 There is a dearth of evidence-based stigma interventions for enacted and other forms of 
stigma in SSA. While stigma is recognized as a multidimensional process, few interventions 
exist to reduce the harms of all types of stigma for PLHIV. Of those that do, the majority are 
found in South Africa, with a predominant focus on interpersonal and intrapersonal stigma and 
mixed results on efficacy (71,72). An intervention in Zambia focused on home-based testing and 
counselling and community awareness for HIV led to decreases in individuals having 
stigmatizing beliefs and attitudes about PLHIV, yet reductions in perceived stigma were not 
observed (73). There is also a scarcity of measures specifically conceptualized, adapted, and 
validated for assessing stigma in SSA (74), especially considering the diverse cultural and 
contextual settings in which PLHIV live across the region (75). This impedes progress in 
assessing the effectiveness of stigma mitigation efforts in SSA. 
2.6 Addressing HIV Stigma in SSA 
 
HIV stigma in Uganda is cited as a pervasive challenge for PLHIV (66,76,77). 
Internalized and anticipated HIV stigma have been found to be increasing in some settings in 
Uganda, as access to HIV treatment and services has expanded (78).  Stigma is also known to be 
a correlate of masculinity in Uganda and threatens the norms expected of men such as 
respectability and independence. HIV thus has been attributed to reducing men in Uganda’s 
likelihood of seeking clinical care for HIV and disclosing their HIV status (79). Pregnant women 
in Uganda have been found to face HIV stigma from HCWs which has been attributed to 
challenges navigating health care for themselves and their unborn children (80). Support groups 
for PLHIV in Uganda are being touted as an integral mechanism for resisting stigma in this 
setting. Support groups have enabled collective action among PLHIV to create social change and 
work together to dispel HIV stigma while also being integral in reducing the self-stigma that is 
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common among PLHIV in Uganda (81). The impact of stigma in Uganda requires increased 
attention and conceptualization of valid measures, as only recent studies have yielded measures 
that have been validated for Uganda specifically around measurement of internalized HIV stigma 
(66).  
The recent development of a scale of cultural conceptions of HIV stigma in Botswana 
represents one of the first efforts to measure stigma and how it impacts the daily lives and 
treatment seeking for PLHIV within a specific SSA setting (75). This study and related work 
focused on the manifestations of cultural HIV stigma in Botswana can pave the way for further 
exploration as to the operationalization of stigma in specific sociocultural settings. Findings 
highlighted that despite legal protections being in place to protect PLHIV from discrimination, 
particularly among men, the negative connotations of HIV threatened masculine ideals and 
contributed to stressors associated with employment insecurity (82,83). Men living with HIV 
expressed experiencing both direct and indirect forms of employment discrimination as the 
mechanisms for protecting PLHIV from discrimination were not abundantly clear. Concealing 
one’s status was also critical to maintaining their employment, thus decreasing the likelihood that 
men would seek support for HIV discrimination despite protections in place (9).  
Among women in Botswana, structural policies such as mandated HIV testing during 
antenatal care positioned them to be the first diagnosed with HIV versus their partner, resulting 
in disproportionate HIV stigma and being blamed for its transmission (10). Botswana 
exemplifies how protections being put in place to mitigate stigma may not be sufficient to 
address the ways that stigma impacts the daily lived experience of HIV. Even policies that are 
meant to promote the health and wellbeing of PLHIV can cause unintentional harm given the 
social and cultural dynamics of HIV.  
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2.7 The Burden of Mental Health among PLHIV in SSA  
 
Extant literature from SSA has demonstrated that PLHIV are at higher risk for mental 
disorders, reduced quality of life, and diminished emotional wellbeing compared to individuals 
not living with HIV(84). Psychological distress, anxiety and depression have also been 
demonstrated as risk factors for increased morbidity (85). Studies have additionally found that 
poor social support, the presence of life stressors, and stigma were associated with an increase in 
the likelihood of depression among PLHIV and that PLHIV who screened positive for anxiety 
were also found to have avoidant coping behavior and be high risk for substance use (86). A high 
prevalence of HIV is therefore a population level dynamic that leads to increased rates of mental 
disorders, which in turn can limit HIV treatment adherence (87,88). In Botswana, it was found 
that depression was highly prevalent in the five districts in the country with the highest HIV 
prevalence rates, with over 30% of men and 25% of women in these districts having high rates of 
depressive symptoms (89). Anxiety disorders among PLHIV in SSA Nigeria have been found to 
be associated with lack of social support, unemployment, and not being married, all of which can 
be potentiated by experiencing stigma (90). 
Few countries in SSA have comprehensive mental health policies and programming in 
place, let alone dedicated initiatives for PLHIV (91,92). Most mental policies call for the 
provision of treatment and protection for individuals living with mental health conditions 
(91,93). Although, many are limited in their human rights-based approaches to the protections 
and implementation of comprehensive services for mental disorders. Countries within SSA that 
are recognized for their mental health policies include both Uganda and South Africa; they are 
known for their comprehensive mental health legislation that recognize the need for service 
quality, advocacy, human rights, and research (94). Despite only a few settings in SSA having 
 
 34 
existing mental health policies, the underdiagnoses and undertreatment of mental disorders for 
PLHIV remains prevalent (92). Many HIV treatment providers have little training in the 
screening and treatment of mental health conditions and SSA has a scarce cadre of mental health 
professionals. Globally the annual rate of visits for mental health is 1,051 per 100,000 while in 
SSA it is 14 per 100,000. There even countries in SSA in which the mental health treatment gap 
is over 90% (95). 
2.8 Specific Population Burden of Mental Disorders in SSA 
 
Specifically, among adult’s living with HIV, there is high psychiatric co-morbidity 
experienced by both women and men in SSA. Extant literature demonstrates that adult PLHIV 
are more likely to be diagnosed with depression compared to people who are not living with HIV 
(96), and depression is the most common mental disorder among adult PLHIV (97). Estimates 
across SSA countries place the prevalence of depression between 14-64% with particularly high 
rates in Uganda and South Africa (87,92). Anxiety is also prevalent among adults living with 
HIV with various studies suggesting a prevalence between 19%-37% (98). Psychiatric 
multimorbity is also common with co-occurring mood and anxiety disorders, and the co-
occurrence of mood and substance use disorders (92).  
 Adolescents are disproportionately at higher risk for mental health conditions given this 
being the typical onset for disorders, regardless of HIV status (99,100). However, ALWH have 
been found to have 1.68 times the odds of depression, 1.77 times the odds of anxiety, and 1.59 
times the odds of conduct disorder compared to peers who are uninfected (101). Studies within 
SSA have also suggested an estimated prevalence of depression among ALWH to range from 
18.9% (102)-46% (103). The prevalence of anxiety was estimated to be as high as 32% among 
ALWH in this context as well (104). ALWH are also more likely to be hospitalized for mental 
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illness compared to their peers who are uninfected with HIV (105). In addition, only 27% of 
countries in SSA have dedicated adolescent mental health beds and in the majority of countries 
there is approximately 1 child psychiatrist for 4 million people (106).  
2.9 Addressing Mental Health in the Context of HIV 
 
 Exploring the ways in which stigma and stressful life events, such as disclosure, 
contribute to poor mental health (92,107)5/24/21 10:09:00 PM, is key to addressing the co-
occurrence of mental health and HIV. Calls for the integration of mental health screening and 
treatment into HIV services are increasing as many countries in SSA are beginning to recognize 
diminished advancements in curbing the HIV epidemic due to co-morbid mental disorders 
(87,108). Efforts to measure the impact of stigma and disclosure as means of informing mental 
health interventions are scaling up in settings with high rates of HIV including Botswana and 
South Africa (109). A recent review used the term “intersecting vulnerabilities” to describe the 
plight of living with both HIV and mental health conditions as it emphasized the structural, 
sociocultural, and intrapersonal dynamics of HIV that are associated with mental health (88). 
Especially for sustained engagement and retention in HIV treatment, mental health and the 
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Chapter 3: Relationships between Mental Health and the HIV Care 
Continuum for Adolescents Living with HIV: A Scoping Review of the 
Literature 
3.1 Abstract 
Introduction: Reviews have examined mental disorders experienced by Adolescents Living 
with HIV (ALWH), yet there is little understanding about mental disorders and the HIV care 
continuum. The aim of this was scoping review was to examine research on mental health and 
engagement in all steps along the HIV care continuum for ALWH in sub-Saharan Africa. 
Methods: PubMed, CINAHL, EMBASE, and PsycINFO were searched through December 31, 
2020. To be included in this review an article had to: present primary data, be from sub-Saharan 
Africa; have a study population of adolescents (age 10-19) living with HIV; be peer-reviewed; 
and assess symptoms or diagnoses of mental disorders in relation to one or more steps of the 
continuum. Title and abstract review were conducted by two authors, and a third author then 
confirmed articles that were selected for full text screening. Full text review involved a similar 
process in which both the first and second author extracted data from each article. Abstract and 
full text review involved double screening utilizing the software Covidence. 
Results: 34 studies were included in this review. Most studies came from Eastern and Southern 
Africa and the majority assessed mental disorders at the HIV treatment step among both older 
and younger adolescents. There was a predominance of cross-sectional studies and use of 
Western conceptualized mental disorder measures. Depression and anxiety were the most 
common disorders examined, followed by general psychological distress, while suicide and post-
traumatic stress disorder (PTSD) were examined in only a handful of studies. ALWH were 
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primarily assessed at the “Engaged or Retained in Care” step of the continuum, with the majority 
of studies taking place prior to initiation of Universal Test and Treat policies.  
Conclusions: The results from this scoping review suggest a predominance of the research 
among ALWH focuses on those engaged in care. The prevalent use of cross-sectional studies 
continues to generate a gap in our longitudinally understanding HIV and psychosocial outcomes 
among ALWH. More attention is also needed for other stages of the continuum, particularly the 
HIV testing and viral suppression steps, in order to comprehensively understand adolescent 
mental health needs and priority timepoints for intervention.   
3.2 Background  
 
Common mental disorders, such as depressive and anxiety disorders, are known to be 
prevalent comorbidities experienced by people living with HIV (PLHIV)(1). PLHIV are more 
likely to be diagnosed with mental disorders compared to individuals who are not living with the 
virus (1–5). As sub-Saharan Africa (SSA) represents approximately 70% of the global burden of 
HIV (1), the mental health of PLHIV in sub-Saharan Africa (SSA) remains a critical aspect of 
HIV care that necessitates attention.  
Adolescents living with HIV (ALWH) are a particularly vulnerable subset of individuals 
within the population of PLHIV in SSA. Various studies among ALWH suggest a high 
prevalence of both depression and suicidality (6–8). This is particularly pertinent as depression is 
one of the leading causes of illness and disability among adolescents globally and suicide is the 
third leading cause of death among 15-19 year olds (9,10). Furthermore, ALWH are especially 
susceptible to mental disorders from a developmental perspective, given the behavioral and 
social changes they are experiencing at this critical age leading into adulthood (11) . 
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The HIV care continuum encompasses a series of steps from diagnosis to viral 
suppression that inform HIV treatment on a global scale (12). ALWH face myriad challenges 
that adults living with HIV do not, and as such, utilizing the care continuum as a framework for 
improving their linkage and retention in care and viral suppression is essential. Critical to this 
point is understanding the steps of the continuum in which ALWH are most engaged (13)(Wood 
et al., 2015) and how psychosocial elements may hinder their successful and sustained transition 
to care in adulthood. While recent reviews have examined the mental health challenges 
experienced by ALWH, understanding mental disorders as they relate to the full HIV care 
continuum remains an extant gap (14,15). To date, no scoping reviews have been published to 
examine research on mental disorders and engagement in all steps along the HIV care continuum 
among ALWH in SSA.  
Objective 
This scoping review seeks to characterize the published literature on mental disorders and 
the HIV care continuum in SSA for ALWH. Specifically, this review will assess the relationship 
between mental disorders (i.e., Depressive Disorders, Anxiety Disorders, Trauma and Stressor 
Related Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, and Disruptive, 
Impulse-Control, and Conduct Disorders) and engagement in each step along the HIV care 
continuum for ALWH ages 10-19 years in SSA.  
3.3 Methods 
 
Definition of Terms 
Adolescents were defined using the World Health Organization (WHO) definition of 
individuals ages 10-19 years of age. Younger adolescents are ages 10-14 and older adolescents 
are ages 15-19 (24,25). We used the HIV care continuum as a framework for understanding the 
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intersection of HIV treatment and mental health assessment and care for ALWH. The care 
continuum exists in two iterations: pre-introduction of Universal Test and Treat and post-
introduction of Universal Test and Treat (UTT) policies. Various studies were suggestive that 
early treatment of individuals living with HIV could be fundamental in the reduction of 
transmission rates (16,17) . Given this, the standard approach to addressing HIV transformed 
from the treatment as prevention model into the concept of UTT in approximately 2016. UTT 
consists of providing both HIV testing and counselling to populations and then antiretroviral 
therapy (ART) to all individuals who are living with HIV (18).  
Prior to UTT, the care continuum consisted of five steps on the pathway from diagnosis 
to viral suppression: 1) HIV diagnosis, 2) linkage to care, 3) engagement or retainment in care, 
4) adherence to ART, and 5) viral suppression. Linkage to care in this case meant no more than 3 
months between HIV diagnosis and initiation of treatment (12). Being engaged or retained in 
care was variously described but commonly defined as having at least 2 or more viral load 
measures at least 3 months apart within the last year. ART adherence was also defined in 
multiple ways, but often was measured through pill counts and patient self-reports. Viral 
suppression was commonly defined as having less then 200 copies per milliliter of HIV obtained 
from a viral load measure that took place within the last year (12).  
Following the establishment of UTT, the care continuum was modified to reflect this new 
strategy and the steps became: 1) HIV diagnosis, 2) linkage to care, 3) receiving HIV Care, 4) 
retainment in HIV care, and 5) viral suppression (19,20)5/24/21 10:09:00 PM. Linkage to care 
post-UTT encompasses having baseline labs taken, enrolling in an ART program and initiating 
ART, and receiving early counselling and adherence support (21). Receiving HIV care is defined 
as the visits that take place after the first follow up that ends the linkage to care step. Retention in 
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care is defined as completing at least 2 or more HIV treatment visits with at least 90 days in 
between and within one calendar year (22). For the purposes of this review, we included studies 
at any of these stages of the HIV care continuum and accepted a range of definitions and 
measures for each step (e.g., a range of ART adherence measures), as long as the intention was 
to measure a step along this continuum in some way.  
For the purposes of this review, included mental disorders are defined as those that fit 
within the following DSM-V domains: Depressive Disorders, Anxiety Disorders, Trauma and 
Stressor Related Disorders, and Schizophrenia Spectrum and Other Psychotic Disorders (23) and 
Suicide. For studies in which general and/or broad measures were used, that could be informative 
of the aforementioned mental disorders, but not diagnostic, we defined these as measuring 
general psychological distress and as eligible for inclusion in this review. Publications that solely 
focused on neurocognitive disorders, (e.g., epilepsy) were not included. In addition, studies that 
focused on alcohol and substance use disorders without consideration of a mental disorder were 
also excluded. However, if a study was eligible because it examined one of the specified mental 
disorder domains in relation to the HIV care continuum but also collected data on alcohol and/or 
substance use disorders, we extracted data on these behavioral conditions to assess their 
interrelationship (i.e., their potential as moderators or mediators of the mental health and care 
continuum relationship).  
Eligibility Criteria  
To be included in this review an article also had to meet the following inclusion criteria: 
1) it presented primary quantitative or qualitative data from SSA; 2) the study population was 
adolescents (age 10-19) living with HIV or data were stratified by age and included this 
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population; 3) it was published in a peer-reviewed journal; 4) it assessed symptoms or diagnoses 
of the specified mental disorders in relation to one or more of the above defined steps of the HIV 
care continuum (i.e., a) HIV testing and diagnosis, b) accessing medical care for HIV, c) starting 
ART initiation, d) ongoing engagement or retention in care for HIV, e) adherence to ART, f) 
viral suppression); and, 5) it was written in English.  
An article was excluded from this scoping review if it met one or more of the following 
criteria: 1) it was a review paper, conference poster, instrument validation paper, conference oral 
presentation, or dissertation; 2) it focused exclusively on alcohol or drug use; 3) the study 
population was people living with HIV with neurocognitive disorders without the assessment of 
a mental disorder; 4) it did not provide information that enabled ascertainment of what step of 
the continuum participants may be on; 5) the study population was only adults (19 years or older) 
or included adolescents but did not stratify by age; and, 6) it did not report HIV status of study 
participants or present information that enabled ascertainment of HIV status.  
Search Strategy 
The search strategy was centered around three overarching domains: the HIV care 
continuum, mental health, and SSA. Search strings for each of these domains were developed 
and linked using AND to identify studies that potentially meet the inclusion criteria. Four 
electronic databases (PubMed, CINAHL, EMBASE, and PsycINFO) were searched through 
December 31st, 2020. 
Data Extraction and Management 
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All data extraction for this review involved the first (OBP) and second author (NW) using 
the software Covidence. First, title and abstract review were conducted by both authors 
separately with any discrepancies jointly discussed. A third reviewer then confirmed articles that 
were selected via this initial process to undergo full text screening. Full text review involved a 
similar process in which both the first and second author confirmed article eligibility, and for 
those eligible, extracted data from each article. Regular meetings among the two authors allowed 
for discrepancies to be addressed. All data from the articles were put into a spreadsheet that 
included indicators for the following: study identification, which included citation, author(s), 
year of publication; study description, including study objectives, location and setting, 
recruitment method, population characteristics, type of mental disorders assessed, mental health 
measurements used, steps in the HIV care continuum (pre and post-UTT), study design, sample 
size, perinatal or behavioral transmission, and whether older and/or younger adolescents were 
included; outcomes, which included analytic approach, outcome measures, comparison groups, 
key findings, conclusions, and limitations. For any studies in which the dates of data collection 
were unclear, study authors were contacted directly and asked to verify whether it was conducted 
to assess the HIV care continuum pre- or post-UTT.  
We also acknowledge that there are various potential ways in which to use the care 
continuum as a framework for understanding the diversity of studies that were reviewed. For this 
review, studies were assigned steps of the continuum based on either the point at which the 
actual analysis examining the relationship between HIV and mental health took place or based on 
the study question guiding the analysis (e.g. examining psychosocial factors related to retention 
in care for ALWH). This review was conducted in consideration of the PRISMA Extension for 
Scoping Reviews (26) and registered with Prospero on August 8th, 2020. 
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3.4 Results  
In total, 6,433 studies were identified through the search, of which 34 were included in 
this review. Figure 3.1 presents a PRISMA flowchart of the results of the article screening. Out 
of the 6,433 studies, 3,720 studies had their titles and abstracts reviewed and 178 went through 
full text review. Of those excluded, the majority were due to either being conducted solely 
among adults or not presenting data stratified by age for adolescents. Tables 3.1 and 3.2 provide 
an overview separately of basic details of all studies conducted pre- and post-UTT, respectively: 
the country in which each study took place, description of the population, type of HIV 
transmission, study design, and mental disorders and care continuum steps assessed. Most 
studies (n=30) took place prior to the passage of UTT policy. Many studies included both older 
and younger adolescents, with 3 focusing on only older and 2 focusing on only younger 
adolescents. Most studies came from South Africa (n=12), followed by Uganda (n=6), Rwanda 
(n=4), Zambia (n=4), and Kenya (n=3). Nigeria, Ghana, Namibia, Zimbabwe, and Malawi each 
had 1 study. There was a predominance of cross-sectional studies (n=25), followed by qualitative 
(n=5), mixed methods (n=3), case-control (n=2) and one randomized controlled trial (RCT) 
(n=1).  
The majority of studies these were among ALWH at the “Engaged or Retained in Care” 
(n=26) step of the continuum. There were also studies that assessed ALWH at both the “Engaged 
or Retained in Care” and “Adherence” (n=4) steps. For the 4 studies that took place post-UTT 
policy implementation, two were with ALWH at the “Received Care” step, one with adolescents 
at both the “Received HIV Care” and “Retained in Care” steps, and one at both the “Received 
Care” and “Viral Suppression” steps.  
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Table 3.3 presents the mental health measures used in each study and is organized by 
type of mental health measure used, and whether it was used with ALWH and/or their 
caregivers. Depression (n=24) and anxiety (n=8) were the most common disorders examined, 
with only a handful of studies assessing post-traumatic stress disorder (PTSD) (n=6), suicide 
(n=4), and conduct problems (n=2); some studies examined combinations of these (n=13). 
General psychological distress measures were used in 13 studies, with 5 of these utilized 
alongside of the mental disorder measures.  
Below, we present selected and summarized results from all studies, first separated by 
pre-UTT and post-UTT, and then by stage of the HIV care continuum; complete findings are 









Table 3.1. Study Descriptions Pre-UTT 
 
 
Citation Country Population Older/Younger 
Adolescents* 
Type of HIV 
Transmission  
Study Design Mental Disorders 
Assessed  
HIV Care 
Continuum Steps  
Abubakar et 
al., 2017 















Uganda 224 ALWH  Both  Not reported Cross-sectional Depression  
Suicide 
Engaged or retained 
in care 
Betancourt 
et al., 2014 













Engaged or retained 
in care 




74 families of ALWH 
 




Engaged or retained 
in care 




1,060 ALWH  Both  Perinatal and 
behavioral 












1,053 ALWH Both  Perinatal and 
behavioral  













Gentz et al., 
2017 
Namibia 99 ALWH Both  Perinatal and 
behavioral  
Cross-sectional  General 
psychological 
Distress 
Engaged or retained 
in care 
Kim et al., 
2017 
Malawi 519 ALWH Both  Perinatal Cross-sectional  Depression  Engaged or retained 
in care  
 
Adherence to ART 




26 ALWH Both  Perinatal and 
behavioral 
Qualitative  Engaged or retained 
in care 




78 ALWH (14 ART 
naïve, 46 on ART 
without HIV-related 
encephalopathy 















Zambia 103 ALWH Both  Not reported Multi-method  General 
psychological 
distress 




Uganda 614 ALWH Both  Perinatal Cross-sectional  General 
psychological 
distress 













Zambia 127 ALWH  
419 Adolescents in 
School (HIV status 
unknown) 
Both  Perinatal and 
behavioral  
Cross-sectional  General 
psychological 
distress 





Uganda 464 ALWH Both  Not reported  Cross-sectional  General 
psychological 
distress 
Engaged or retained 
in HIV care 
 
Adherence to ART 
Mutumba et 
al., 2017 
Uganda 464 ALWH Both  Both  Cross-sectional  General 
psychological 
distress 
Engaged or retained 
in care 
Nalukenge Uganda 19 ALWH Both  Perinatal Qualitative Depression Engaged or retained 
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et al., 2017 
Rwanda 218 ALWH  





Both  Not reported Cross-sectional  Depression 
 
Anxiety 
Engaged or retained 
in care 
Ng et al., 
2015 







Both  Not reported Case control  Depressiona  
Anxietyb 




Zambia 190 ALWH Older Not reported Mixed Methods Depression  Engaged or retained 
in care 
 
Adherence to ART 
Osok et al., 
2018 
Kenya 14 pregnant ALWH 
163 pregnant 
adolescents who were 
not diagnosed with HIV 
at time of study  














Both  Not reported Qualitative N/A Engaged or retained 
in care 




1,024 ALWH  Both  Perinatal and 
Behavioral  




Engaged or retained 
in care 
Smith 
Fawzi et al., 
2016 




Anxiety measure  
 
Engaged or retained 
in care 
 
Adherence to ART 
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278 ALWH Both  Perinatal and 
behavioral 
Cross-sectional  Depression 
Anxiety 
PTSD 
Suicide ideation  
Engaged or Retained 
in Care 
Willis et al., 
2018 
Zimbabwe 21 ALWH  Older Perinatal and 
behavioral 












Engaged or retained 
in care 
a Both adolescents and caregivers  
b Caregivers  
*Older/Younger indicates whether ALWH are older as defined by WHO (15-19) or younger (10-14) 


























Table 3.2. Study Descriptions Post-UTT 
 *Older/younger indicates whether ALWH are older as defined by WHO (15-19) or younger (10-14) 
Citation Country Population Older/Younger  
Adolescents* 
Type of HIV 
Transmission 














Enane et al., 
2019 
Kenya 6 hospitalized ALWH, 16 
caregivers of hospitalized 
ALWH, 11 non-disclosed 
engaged ALWH, 55 
disclosed engaged 
ALWH, 28 caregivers of 
engaged ALWH  
 





Kagee et al., 
2019 











Uganda 336 ALWH Both  Not reported Cross-
sectional  








Table 3.3. Mental Health Measures  
 
 
Quantitative Measures  
Beck Depression Inventory (BDI-11) ALWH 2 studies: (Abubakar et al., 2017; Kim et 
al., 2017) 
Caregivers: 1 study (Abubakar et al., 2017) 
Child Behaviour Checklist (CBCL) ALWH 1 study: (Louw et al., 2016) 
Child Depression Inventory (CDI) ALWH 7 studies: (Bhana et al., 2014; Boyes et 
al., 2019; Casale et al., 2019; Pantelic et al., 
2017; Sherr et al., 2018; West et al., 2019; 
Woollett et al., 2017) 
Children’s Depression Rating Scale-Revised (CDRS-R) ALWH: 1 study (Kim et al., 2017) 
Center for Epidemiologic Studies Depression Scale (CES-
D) 
ALWH 1 study: (Okawa et al., 2018) 
Center for Epidemiological Studies-Depression Scale for 
Children (CES-DC) 
ALWH 5 studies: (Betancourt et al., 2014; 
Kemigisha et al., 2019**; Nduwimana et al., 
2017; Ng et al., 2015; Smith Fawzi et al., 2016) 
Child PTSD Checklist  ALWH 4 studies: (Boyes et al., 2019; Sherr et 
al., 2018; West et al., 2019; Woollett et al., 
2017) 
Edinburgh Postnatal Depression Screen (EPDS) ALWH 1 study: (Osok et al., 2018) 
Hopkins Symptoms Checklist-25 (HSCL-25) Caregivers 2 studies: (Betancourt et al., 2014; 
Ng et al., 2015) 
ICD-10 Major Depression Inventory (MDI) ALWH 1 study: (Enimil et al., 2016) 
Mini International Neuropsychiatric Interview for 
Children and Adolescents (MINI-KID) 
ALWH 5 studies: (Adeyemo et al., 2019; Ashaba 
et al., 2018; Casale et al., 2019; Sherr et al., 
2018; Woollett et al., 2017) 
Medical Outcomes Study HIV Health Survey instrument 
(MOS-HIV) 
ALWH 1 study: (Mbalinda et al., 2015) 
Patient Health Questionnaire (PHQ-9) ALWH 1 study: (Osok et al., 2018) 
Pediatric Quality of Life Inventory (PedsQL) ALWH 1 study (Kagee et al., 2019**) 
Revised Children’s Anxiety and Depression Scale 
(RCADS) 
ALWH 2 studies: (Coetzee et al., 2019**; Kagee 
et al., 2019**) 
 Revised Children’s Manifest Anxiety Scale (RCMAS) ALWH 4 studies: (Boyes et al., 2019; Sherr et 
al., 2018; West et al., 2019; Woollett et al., 
2017) 
Strengths and Difficulties Questionnaire (SDQ) ALWH 6 studies: (Bhana et al., 2014; Boyes et 
al., 2019; Gentz et al., 2017; Lyambai & Mwape, 
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2018; Menon et al., 2009; Menon et al., 2007) 
Study Designed Conduct Problems Measure ALWH 1 study: (Betancourt et al., 2014) 
Study Designed Psychological Distress Measure ALWH 2 studies: (Mutumba et al., 2016; 
Mutumba et al., 2017) 
World Health Organization Disability Assessment 
Schedule for Children (WHODAS-Child) 
ALWH 1 study: (Betancourt et al., 2014) 
World Health Organization Self-Report Questionnaire 
(SRQ-25) 
ALWH 1 study: (Musisi & Kinyanda, 2009) 
World Health Organization – Five Well-Being Index 
(WHO-5) 
ALWH 1 study: (Enimil et al., 2016) 
Youth Conduct Problems Scale–Rwanda (YCPS-R)  ALWH 1 study: (Ng et al., 2015) 
Youth Self-Report (YSR) Internalizing Subscale ALWH 3 studies: (Betancourt et al., 2014; 
Nduwimana et al., 2017; Ng et al., 2015) 
Qualitative Measures  
Body Mapping ALWH 1 study: (Willis et al., 2018) 
Focus Groups ALWH 3 studies: (Bhana et al., 2014; Enane et 
al., 2019**; Li et al., 2010) 
In Depth Interviews ALWH 4 studies: (Bhana et al., 2014; Enane et 
al., 2019**; Nalukenge et al., 2019; Petersen et 
al., 2011) 
*Refers to the instrument used, whether the entire instrument or a section 
**Study conducted Post-UTT 
 
HIV Care Continuum and Mental Health Pre-UTT 
“Engaged or Retained in Care” 
 Twenty-six studies prior to UTT took place at the “Engaged or Retained in Care” step of 
the continuum. South Africa had the highest number of studies (n=10), then Uganda (n=4), 
Rwanda (n=3), Zambia (n=3), Kenya (n=2), Nigeria (n=1), Ghana (n=1), Namibia (n=1), and 
Zimbabwe (n=1). Most used cross-sectional study designs (n=17), followed by qualitative (n=4), 
case control (n=2), mixed methods (n=1), multi-methods (n=1), and RCT (n=1). Most of the 
studies were among both older and younger adolescents, with 1 study among just younger and 2 
with only older adolescents. Perinatal (n=6) and both perinatal and behavioral infection of 
adolescent participants (n=9) were commonly reported; however, almost half of the studies did 
not report mode of transmission (n=10). Across studies, sample sizes of adolescents ranged from 
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14-1,060 ALWH. Depression, anxiety, general psychological distress, PTSD, and suicidal 
ideation were the mental disorders that were measured within these studies.  
Internalizing and Externalizing Symptoms 
Measures for general psychological distress, depression, and anxiety were used to assess 
internalizing (i.e., anxiety, sadness, self-isolation) and externalizing (i.e., aggression, lack of 
impulse control, overactivity) symptoms in 6 cross-sectional studies (27,28). There were 2 
studies that took place in Zambia, and 1 each in South Africa, Namibia, Rwanda, and Uganda. 
The studies included ALWH who were either perinatally or behaviorally infected, with 1 study 
not reporting on transmission type. 
Two studies examined predictors of internalizing and externalizing symptoms. A 
Namibian study found that poverty (β =-0.231, p=0.023) and stigma (β =0.268, p=0.009) were 
key predictors for overall mental health difficulties for ALWH and stigma was also predictive of 
emotional symptoms alone (β =0.314, p=0.002) (29). In South Africa, only caregiver depression 
was found to be a statistically significant predictor of Total Problem Scores given the Child 
Behavior Checklist (CBCL) (F = 8.57, df = 5.102, p < .01) (30). A Ugandan study demonstrated 
that ALWH had 5 times the odds of having better mental health if they were in secondary school 
compared to those without any education (adjusted odds ratio (AOR) 5.3, 95% CI [ 1.86–15.41]), 
and those on ART had 4 times the odds of having better mental health compared to ALWH not 
on ART (AOR 3.9, 95 % CI [2.22–6.9]). Not having caregivers to discuss sexuality and those not 
satisfied with sexual and reproductive health services were also less likely to have good mental 
health (AOR 0.34, 95% CI [0.18–0.62]; AOR 0.6, 95% CI [0.40–0.89] respectively) (33). 
The two studies from Zambia compared ALWH to uninfected adolescents. The first 
found that ALWH in Zambia had 2 times the odds of greater total difficulties scores (odds ratio 
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(OR) = 2.1, 95% CI [1.4 to 3.1]), 3 times the odds of having high scores for emotional symptoms 
(OR = 3.6, 95% CI [2.5 to 5.4]) and 7 times the odds to score abnormally for peer problems (OR 
= 7.1, 95% CI [4.9 to 10.2]) compared to a UK sample (31). The second study compared a 
Zambian school sample and UK normative sample to ALWH and results showed ALWH had 
higher total difficulty scores (School sample (a): 27.8% (116); UK(b):16.5% (698); HIV+(c): 
29.1% (37) a vs c OR=0.9 (0.6-1.4) c vs b OR=2.1 (1.4-3.1) and emotional symptoms ( School 
sample(a): 30.1% (126), UK(b) 11.2% (474), HIV+(c) 31.5% (40), a vs c OR=0.9 (0.6-1.4) c vs 
b OR=3.6 (2.5-5.4). Conversely, a study from Rwanda found that being HIV positive did not 
predict psychological aggression (Beta= −0.03 (−.09, 0.10) or daily hardships (Beta=0.05 95% 
CI [−0.54, 0.65], p=0.86) (32). 
 Overall, studies that focused on internalizing and externalizing symptoms showed that 
caregivers were critical in regard to psychopathology. In addition, while school was an important 
factor in mitigating mental health challenges, among ALWH, it did not ameliorate the 
heightened presentation of said challenges when compared with uninfected individuals also in 
school.  
Depression 
 While depression had the most different number of measures used in its assessment 
across studies, depression was looked at as an outcome in 4 studies. Out of the 4 studies, 2 were 
conducted in Kenya, 1 in South Africa, and 1 in Zimbabwe. Two were conducted only among 
older adolescents and 2 with both older and younger adolescents. One had adolescents who were 
both perinatally and behaviorally infected, 1 only perinatally infected adolescents, and 2 did not 
report on transmission.  
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The cross-sectional study from Kenya was suggestive of a main effect that living with 
HIV was associated with having higher mean depression scores (18.4 [SD = 8.3) compared to 
HIV affected adolescents (16.8 [SD = 7.3]) and community controls (12.0 [SD = 7.9]) (34). The 
other study from Kenya was also cross-sectional. This study was among pregnant adolescents 
and found myriad factors that contributed to high depression scores including younger age (i.e. 
15-16 years old compared to 17-18 years) (F(2, 173) = 18.63; p < 0.001), lack of social support (t 
(174) = 8.0; p < 0.001), stressful life events (t (174) = − 8.2; p < 0.001), and a positive HIV 
diagnosis (t (174) = − 4.0; P < 0.001) (35).  
The study from South Africa was also cross-sectional and examined correlates of 
internalized HIV stigma, with consideration for enacted stigma as well. Internalized HIV stigma 
was attributed to depressive symptoms (β = 0.445, p < .001) and living in an urban household. 
Enacted HIV stigma (β = 0.294, p < .001) and abuse victimization (β = 0.396, p < .001) were 
found to be associated with  more depressive symptoms for adolescents (36).  
 In the qualitative study from Zambia, ALWH described thinking of their depression as 
related to relationships in their lives, especially with wanting to feel valued by family and 
friends. They also felt they were different from others due to their HIV status and commonly felt 
isolated or rejected. Critical to coping were supportive family members and friends, and 
psychosocial support programs (37).  
  Overall, depression was associated with HIV status and lack of social support as critical 
factors for its onset.  
Distress 
There were 3 studies that examined distress as their main outcome, one each in Ghana, 
Uganda, and in Zambia. Cross-sectional, mixed methods, and multi-methods were the study 
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designs, the studies included both older and younger adolescents. Only 1 study had adolescents 
who were perinatally and behaviorally infected, 1 included ALWH who were only perinatally 
infected, and 1 did not report transmission. General psychological distress and depression 
measures were used.  
The study from Ghana found that ALWH had lower psychological health scores (mean 
difference= −3.26, 95% CI [−4.19 to −2.33]) compared to international age-based sample and a 
regional sample of mixed ages. This study also obtained qualitative data and found that poor 
treatment by family and peers and loss of relatives were among key challenges for ALWH, while 
religion, self-isolation, and social support were identified as coping mechanisms (38). With the 
Ugandan study, daily hassles (β = 0.179, p < .001), negative life events (β = 0.221, p < .001), 
HIV-related concerns (β = 0.323, p < .001), and stigma (β = 0.155, p < .001) were significantly 
associated with psychological distress (39). From Zambia, ALWH reported multiple mental 
disorders (57.3%) such as emotional and peer related challenges. It was also observed that where 
the adolescents received care in this study, that there was little understanding among nursing 
staff on adolescent mental health which contributed to the scarce measurement of disorders (40).  
Overall, the studies from Ghana and Uganda are suggestive of the role of stigma 
impacting the distress levels of ALWH, while all 3 studies indicated the role of social 
connections as both a protective factor from and facilitator of distress. 
Qualitative Explorations of Mental Health 
 Three studies were qualitative explorations of mental health among ALWH. All 3 
included both older and younger adolescents: 1 included ALWH who were perinatally and 
behaviorally infected, 1 included ALWH who were only perinatally infected, and the other did 
not report on transmission. Mental health measures were not used in any of these studies.  
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Two studies took place in South Africa. The first study found that the ALWH felt poorly 
about their HIV status and had mixed emotions about the future ranging from being both happy 
and depressed to both confident and nervous (41). The second study from South Africa assessed 
both risk and protective factors for psychosocial challenges among ALWH. Common themes 
among adolescents were found to be feeling alone in the world due to their HIV status, not being 
able to express distress from HIV given HIV stigma in their families, and having suicidal 
ideation and aggressive behavior due to poor social support (42).The third qualitative study was 
done in Uganda and it found that HIV-related illness and the effects of ART led to mental health 
challenges as well as challenges with family illnesses, abuse and discrimination (43).  
The qualitive studies elucidated challenges with the knowledge of one’s HIV status as 
well as the effects of being on treatment.  
Sociodemographic Characteristics in Association with Multiple Mental Disorders  
There were 3 studies that included multiple mental disorders as their outcomes of interest. 
One was a case control study from Rwanda among both older and younger adolescents for whom 
HIV transmission model was not reported. This study used measures for depression, anxiety, and 
general psychological distress. This case-control study compared HIV-infected and uninfected 
youth; the former had higher odds of depression (OR = 1.32, 95% CI [0.90 to 1.95]), anxiety 
(OR=1.13, 95% CI [0.71 to 1.81]), and conduct problems (OR = 1.34, 95% CI [0.86 to 2.10]) 
(44). Two studies from South Africa included older and younger ALWH who were perinatally 
and behaviorally infected. One study measured depression, anxiety, PTSD, and general 
psychological distress and focused on correlates of mental health problems. They found relevant 
predictors included ART side effects, internalized and enacted stigma, negative clinic 
interactions, emotional abuse and bullying (45). The second examined the association between 
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psychosocial factors and mental health outcomes. This latter study found that better social 
support was attributed with fewer depression symptoms (adjusted prevalence ratio (aPR) 0.25, 
95% CI [ 0.10–0.59]) and fewer anxiety symptoms (aPR 0.30, 95% CI [0.13–0.71]), but not 
fewer PTSD symptoms (aPR 0.47, 95% CI [0.06–3.49]) (46).  
Suicide 
Only 1 study specifically assessed predictors of suicide among ALWH and it was 
conducted in Rwanda. The study sample included ALWH who were both older and younger in 
terms age. It did not present the mode of HIV infection and was a case control study.The study 
indicated that living with HIV was not a significant predictor of suicide ideation (AOR 1.04, 
95% CI [0.52–2.08], p=0.91) or suicidal behavior (AOR: 1.80, 95% CI [0.87–3.69], p=0.11). 
However, living with HIV was a significant predictor of suicidal behavior when compared to 
adolescents unaffected by HIV (OR: 1.85 95% CI [1.12-3.05]) (47). 
 There were 2 cross-sectional studies that looked at associations of psychosocial factors 
with suicide and for which only suicide was measured. A study took place in Nigeria with 201 
with both older and younger adolescents, for whom HIV transmission was not reported. The 
other study was conducted in South Africa with ALWH that were also both older and younger 
and both perinatally and behaviorally infected. The study with ALWH in Nigeria found that the 
loss of a family member was the only factor associated with current suicide ideation (B=1.570, 
SE: 0.536, WALD: 8.568, p=0.003, OR =4.807) (48). The study from South Africa showed HIV 
stigma being associated with higher depressive symptoms (B= 0.295, p < .001) and higher 
suicidal ideation and behavior (B = 0.185, p < .001), with depression also attributed to higher 
suicidal ideation and behavior (B = 0.164, p < .001) (49).  
Mode of Infection 
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A cross-sectional study from South Africa focused on mode of infection as the outcome. 
ALWH were both older and younger and both perinatally and behaviorally infected. The study 
utilized depression, anxiety, PTSD, and suicide measures. It found that ALWH who were 
behaviorally infected presented with more depression (B = 0.456, p = 0.018), anxiety (B = 1.192, 
p < 0.001), and substance use (OR = 2.99 p = 0.001), with older adolescents specifically being 
more likely to report depression as well (B = 0.09, p < 0.001) (50). 
Risk Factors for Mental Disorders 
But there was only one study that assessed risk factors for mental disorders. The study 
was done in South Africa and included 343 ALWH who were both older and younger and 
perinatally and behaviorally infected. This cross-sectional study used depression, anxiety, PTSD, 
and suicide measures. Regarding key risk factors, ALWH who had been inappropriately touched 
had higher risk for depression (risk ratio (RR) = 2.22, p= 0.01) PTSD (RR = 3.08, p = 0.02), and 
anxiety (RR = 1.77, p =0.00). In addition, forced sex was significantly associated with higher 
risk of depression (RR = 3.55, p = 0.02), anxiety (RR = 3.01, p = 0.01), and PTSD (RR = 2.38, p 
=0.04). This study also elucidated that feeling unsafe at home was associated with a higher 
likelihood of depression (RR = 5.17, p=0.00), anxiety (RR = 2.92, p =0.00), and PTSD (RR = 
3.94, p =0.02). Absence of a safe community space for adolescents also increased risk for 
depression (RR = 2.31, p =0.00), anxiety (RR = 2.02, p = 0.00), and PTSD (RR = 3.66, p =0.01) 
(8). 
Bullying  
Bullying was the focus of only 1 study and was examined in association with depression and 
suicidality. ALWH were both older and younger, and their mode of infection was not reported 
participated. Major Depressive Disorder, specifically, was significantly associated with bullying 
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(AOR = 1.09; 95% CI [1.00–1.20], p = 0.04), while suicidality was significantly associated with 
both bullying (AOR = 1.09; 95% CI [1.01–1.17], p = 0.02) and stigma (AOR = 1.30; 95% CI 
[1.03–1.30], p = 0.02) (6). 
Intervention 
 There was a single study that evaluated a psychosocial intervention for ALWH and it was 
done in South Africa. ALWH participated in an RCT to assess a program that sought to mitigate 
mental health outcomes for younger adolescents who were perinatally infected. The RCT used 
measures for depression and general psychological distress. With the family based psychosocial 
program, depression scores notably improved (mean scores (higher worse): Comparison group: 
baseline: 3.19, follow up: 2.64; intervention: baseline: 3.31, follow Up: 2.03, Beta= -0.736, 
p=0.417). In addition, internalizing and externalizing behaviors also had positive changes (mean 
scores (higher worse): Comparison group: baseline: 18.80, follow up: 18.38; intervention: 
baseline: 18.79, follow up: 16.96, Beta=-1.412, p=0.371) (51). 
“Engaged or Retained in Care” and “Adherence” 
The remaining 4 studies that took place prior to UTT each engaged with ALWH at both 
the “Engaged or Retained in Care” and “Adherence” steps. All looked at psychosocial factors in 
association with adherence. A study took place in Malawi, Rwanda, Uganda, and Zambia and 
had 1,366 adolescents across all 4 studies. There were 3 studies that included older and younger 
adolescents, while 1 just had older. There were 3 studies that did not report on transmission and 
1 had perinatally infected ALWH. In addition, there were 3 cross-sectional studies conducted 




With the Malawian study, depression (AOR 1.7, 95% CI [1.08–2.70], p = 0.02) was 
associated with nonadherent behaviors (52). In Rwanda, it was found that nonadherence was 
associated with various mental health symptoms including irritability (self-report OR = 1.79, 
95% CI [1.06– 3.04]; caregiver report OR = 1.97, 95% CI [1.22–3.18]) and conduct problems 
(self-report OR = 1.79, 95% CI [1.10– 2.90]; caregiver report OR = 3.35, 95% CI [2.00–5.61]). 
Conduct problems remained associated with nonadherence in multivariate analyses (caregiver 
report, OR = 2.90, 95% CI [1.55–5.43]) as well as depression (caregiver report, OR = 1.02, 95% 
CI [1.01–1.04]), with depression found to also be minimally significant given self-report from 
ALWH. In addition, while self-report of depression and anxiety symptoms were not found to be 
associated with adherence (OR = 1.68, 95% CI [0.92–3.07]), caregiver reports indicated a 
positive association with adherence (OR = 3.57, 95% CI 1.86–6.86) (53).  
The Ugandan study showed that psychological distress was associated with nonadherence 
(OR = 1.75, 95% CI [1.04–2.95]), with social support being the only psychosocial resource that 
was significantly associated (OR = 0.42, 95% CI [0.22–0.79]) with nonadherence (54). However, 
the Zambian assessment found that scoring high for depression was not associated with 
nonadherence (AOR: 0.37, 95% CI [0.13–1.01], p=0.16), yet psychological distress was related 
to challenges with treatment for ALWH (55).  
Overall, studies that were done at both the “Engaged or Retained in Care” and 
“Adherence” steps mostly found that depression was associated with nonadherence, with 1 
conflicting study. Distress was also commonly assessed in regards to adherence and found to 
impede treatment.  
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HIV Care Continuum and Mental Health Post-UTT 
Only 4 studies were conducted following UTT. Of these studies, 2 were conducted in 
South Africa, 1 in Kenya and in Uganda. All studies included both older and younger 
adolescents. Three did not report transmission, and 1 reported perinatal transmission. Depression 
and anxiety were assessed in 2 studies, with 1 of these also measuring general psychological 
distress. There was also 1 study that did not include a mental health measure and used qualitative 
methods. Half of the studies were with ALWH at the “Received HIV Care” step. Across all 
studies, the number of participants ranged from 6-336. There was a study that also assessed 
ALWH at both the “Received HIV Care” and “Retained in Care” steps, and the other at the 
“Received HIV Care” and “Viral Suppression” steps. 
“Received Care” and “Retained in HIV Care” 
 Regarding the one qualitative study that took place post-UTT in Kenya, salient themes 
around mental health were explored. Depression and alcohol use, for example, were found to be 
salient among adolescents who were disengaged from care. Various forms of stigma and 
interpersonal conflict also lead to poor mental health. However, participants also stressed the 
importance of being motivated to stay health and received HIV education for them to remain 
adherent to HIV treatment (7).  
“Received Care” 
Post-UTT, understanding the association between quality of life and HIV was the focus 
of 2 studies, both of which were the only ones to take place at the “Received Care” step. Both 
were cross-sectional studies from South Africa. Adolescents were younger and older and the 
mode of infection was not reported in either study. Measures used in the studies were for 
depression, anxiety, and general psychological distress.  
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Both found significant associations indicating that common mental disorders were 
associated with poorer quality of life. One study specifically found both depression (β=0.32, t 
2.03, p=0.00) and anxiety (β=0.15, t 1.87, p=0.04) to be significant predictors of quality of life 
for ALWH (56). The second also found depression to be a predictor of fatigue (Beta=10.904, 
SE= 2.675, Beta 0.311, t=4.076, p=.000), thus impacting quality of life for adolescents (57).  
“Received Care” and “Viral Suppression” 
 Only 1 study in this review was among ALWH at both the “Received Care” and “Viral 
Suppression” steps. This is also the only study that is in consideration of viral suppression (i.e. 
had any analysis that examined this) as a continuum step in the overall review. The cross-
sectional study from Uganda measured depression among 134 older and younger ALWH for 
whom their transmission type was not reported. It found that the odds of having depressive 
symptoms were 1.7 times higher for ALWH who had to travel more than half an hour to get to a 
clinic compared to those who did not have to travel as far (AOR= 1.66 95% CI [1.02-2.70], p = 
0.041) (58). 
Measurement of Mental Health  
Throughout the studies presented in this scoping review there was a predominance of 
Western Conceptualized measures used for mental health as presented in Table 3.3. The Child 
Depression Inventory (CDI) (n=7), Center for Epidemiological Studies-Depression Scale for 
Children (CES-DC) (n=5), and the Mini International Neuropsychiatric Interview for Children 
and Adolescents (MINI-KID) (n=5) were the measures found to be most prevalent among all 
studies. In addition, most measures were used in studies pre-UTT, with the CES-DC, Pediatric 
Quality of Life Inventory (PedsQL), and Revised Children’s Anxiety and Depression Scale 
(RCADS) used in research post-UTT. Furthermore, only 3 studies overall assessed mental 
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disorders among both ALWH and caregivers, using the Beck Depression Inventory (BDI-11) 
(n=1) and the Hopkins Symptoms Checklist-25 (HSCL-25) (n=2). Finally, there were a few 
studies that applied qualitative methods (n=7) with in depth interviews (n=3), focus groups 
(n=2), both focus groups and in-depth interviews (n=1), and body mapping (n=1) used. Of those 
that had qualitative techniques, only 1 study was done post-UTT. 
3.5 Discussion 
 
The purpose of this scoping review was to explore the current literature on the 
relationship between mental health and the HIV care continuum for ALWH in SSA. 34 studies of 
both older and younger ALWH were included in this review, with most studies stemming from 
Eastern and Southern Africa. There was a predominance of cross-sectional studies and the use of 
mental health measures conceptualized in high income countries. Depression and anxiety were 
the most common disorders examined, followed by general psychological distress; suicide and 
post-traumatic stress disorder (PTSD) were examined in only a handful of studies. ALWH were 
primarily assessed at the “Engaged or Retained in Care” step of the continuum, with the majority 
of studies taking place prior to UTT.  
 There were clear gaps in knowledge along different steps of the HIV care continuum and 
at which ALWH may not be receiving mental health screening or treatment for mental health 
conditions. Only one study in the entire review considered mental health and HIV treatment in 
association with viral suppression (58) and no studies took place at either the “HIV diagnosis” or 
“Linked to Care” steps, either pre or post-UTT. Currently 80% of ALWH live in SSA, with 
many remaining unaware of their HIV status (62). While perinatal transmission has dramatically 
reduced across SSA, behavioral infection among adolescents is a key driver in the increasing 
incidence of HIV for youth (63) and this has been raised as a monumental challenge in meeting 
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the 95-95-95 goals (60). In some ways, the findings on linkage to care are representative of the 
current landscape in terms of engaging ALWH in healthcare in SSA. In the era of UTT, despite 
advances in providing more accessible HIV care for adults, there remains limited youth friendly 
HIV programs across SSA (59–61).  
Key populations have also been recognized as requiring attention in terms of HIV 
research and initiatives (64). Despite the importance of key populations driving the HIV 
epidemic in SSA, we only found one study that had a sub-population of ALWH, although not 
considered one of the key populations by UNAIDS (64): pregnant women (35). We know that 
sexual minorities, sex workers, persons who use substances, and adolescents are included in the 
UNAIDS definition of key populations in need (64). However, these categories of individuals are 
not mutually exclusive and as such not having any studies that consider mental health and HIV 
care among these populations who are youth is cause for concern (65,66). Adolescents who are 
sexual minorities, young individuals who inject drugs, and sex workers are known to be some of 
the most vulnerable to HIV and HIV-related complications (66). For example, one review found 
that a third of youth who were sexual minorities exhibited mental health conditions as 17% were 
found to have conduct disorder, 15% depression, and 9% PTSD (67). Mental health conditions 
are a known risk factor for HIV and high rates of mental health conditions amongst these 
populations will continue to drive the epidemic (68). Mental health conditions are also associated 
with higher prevalence of substance use and high-risk sexual behaviors among ALWH (14). 
However, in terms of the broad literature on ALWH, few studies focus on young individuals who 
are engaged in sex work, use substances, and who sexual minorities, that can speak to the 
challenges of risk factors for HIV as well as retention in HIV care for these specific groups (69); 
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which therefore has implications for understanding the impact of mental health in association 
with HIV for these youth.  
Regardless of whether a key population of youth or not, the implications for the lack of 
mental health assessment in conjunction with HIV care, especially during testing and treatment 
initiation, also warrants attention as demonstrated by this review. The onset of mental health 
disorders commonly takes place during adolescence (70) and as adolescence is a critical 
developmental life stage, there are numerous risk factors that may perpetuate an adolescent 
developing a mental health condition. Factors such as peer pressure, sexual debut, and 
developing a sense of self are all well-known correlates of stress during adolescence (71). 
ALWH contend with these factors just as any other youth, yet have nearly double the risk for 
developing both depression and anxiety compared to adolescents who are not living with HIV 
(14). It is also important to acknowledge that despite depression and anxiety being highly 
prevalent disorders for ALWH (14), consideration needs to be taken given to under-researched 
psychosocial correlates of HIV such as suicide and PTSD. In SSA, rates of suicide among 
ALWH range from an estimated 4%-35% in SSA (6,72,73), however was only measured in 2 
studies in this review (6,72). PTSD was only found among 4 studies in this review, yet PTSD can 
be common among ALWH, especially those who have lost parents to AIDS (8).  
 The overreliance on mental health measures conceptualized in high income countries is 
something to be emphasized as these measures can only be so informative of the extent of poor 
mental health if adaptation and validation are not rigorously conducted (74). Many researchers in 
global mental health will utilize qualitative methods to inform the adaptation of psychosocial 
measures or conduct qualitative studies on mental health factors exclusively (75,76). However, 
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this review found very few studies that either utilized measures conceptualized with SSA or 
qualitative methods to understand the context of mental health for ALWH in SSA.  
 A final key challenge is that while many of the included studies assessed mental health 
among ALWH at a certain point in the care continuum, most did not actually assess the 
relationship between mental disorders and engagement in the care continuum; e.g., there were 
limited studies that compared mental health among those engaged and not engaged in treatment. 
This is particularly true for longitudinal studies that might assess how living with a mental 
disorder may or may not predict engagement in care after identified as living with HIV. Not 
having knowledge of the causal relationship between HIV and mental health limits our ability to 
conceptualize both preventative and treatment approaches for ALWH who are also living with 
mental health conditions.  
 The results of this scoping review should be interpreted in light of several limitations. The 
exclusion of non-English title, abstract, and papers may have limited our ability to capture 
relevant work on the intersection of HIV and mental health in a SSA context, particularly from 
areas of West Africa that may have been published in French journals. Our results may therefore 
only be generalizable to English speaking countries, but our search criteria have provided 
breadth of knowledge within this context consistent with the goals of a scoping review. We also 
did not evaluate quality of the included studies, though by extracting study design we have 
identified the common limitations of existing studies.  
Conclusion 
 The studies presented in this review are unable to inform understanding of a 
comprehensive set of psychosocial factors that are associated with ALWH’s HIV treatment. 
Given what this review has found, the literature as it stands on ALWH is not capturing the full 
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extent of the process of going from HIV testing to viral suppression in conjunction with mental 
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Chapter 4: Self-Disclosure of HIV Status and the Relationship to Mental 
Health among ALWH in Uganda 
4.1 Abstract  
Introduction: The current literature on ALWH and HIV status disclosure is scarce. HIV status 
disclosure is recognized as an important process in receiving social support when living with 
HIV. However, self-disclosure can also lead to poor psychosocial outcomes and diminished HIV 
treatment adherence. The limited evidence as to the mental health implications in regards to 
adolescent choice of disclosure requires attention.  
Methods: Secondary analysis was conducted using data from the Pediatric HIV/AIDS Research 
Project (PHARP) in Uganda. Basic frequencies were calculated to assess how often ALWH 
chose to self-disclose to different types of individuals. One-way ANOVA was used to assess 
associations between sociodemographic factors and self-disclosure choice, and multiple linear 
regression was then used to explore the associations between disclosure variables and z-scores 
for depression and anxiety for the top four types of individuals adolescents reported most 
frequently self-disclosing to, number of types of individuals an adolescent self-disclosed to, and 
whether the adolescent reported self-disclosure to anyone. 
Results: The majority of ALWH in this study had disclosed to at least one person with status 
disclosure to one’s mother, father, sister(s), or brother(s) as the most common individuals 
adolescents chose to disclose to. Disclosure to any of these specific nuclear family members was 
not significantly associated with depression or anxiety symptoms. ALWH who had disclosed to 
any person reported lower depression and anxiety symptoms; however, a significant association 
was only observed with depression.  
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Conclusions: Our findings indicate an association between HIV status self-disclosure by 
adolescents and depression symptoms. The relative frequency with which adolescents disclose to 
their nuclear family members highlights the importance of targeting these family members in 
interventions aimed at improving the psychosocial health of ALWH. Further research to confirm 
these associations, explore directionality, and to understand the reasons why ALWH favored 
disclosure to nuclear family members over others is a critical next step in guiding supportive care 




Almost half a million young individuals between the ages of 10-24 were newly infected 
with HIV in 2019 (1), and of the 2 million adolescents living with HIV (ALWH) globally, an 
estimated 70% were perinatally infected (2). The majority of these young individuals living with 
HIV, approximately 80%, reside in sub-Saharan Africa (SSA)(3). While more infants who were 
peri- or postnatally infected with HIV are surviving childhood, they remain vulnerable to 
advanced HIV-infection as they age. Further, ALWH have to contend with co-morbidities and 
disabilities, such as mental illness and neurodevelopmental conditions, while navigating a 
healthy transition to adulthood (3–6).  ALWH are therefore an essential group to engage in the 
creation of developmentally tailored HIV/AIDS treatment and prevention interventions.   
A focus on the psychosocial needs of ALWH is a critical part of the imperative to 
develop tailored treatment strategies, given that the first onset of many mental disorders 
commonly occurs during this developmental stage (7). ALWH are at increased risk of both 
depression and anxiety given the various psychosocial challenges they may experience living 
with a chronic illness, including feeling pressure to conceal their status and the limited social 
support they may have available to them on account of stigma (8–10). Poor mental health and 
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lack of social support have been observed to be significant impediments of health seeking 
behaviors and adherence to antiretroviral therapy (ART)(11). Irregular adherence to ART and 
high-risk behaviors lead to suboptimal treatment effects for ALWH, increasing their own 
morbidity, mortality  and risk for transmitting HIV (12) . Alternatively, promoting positive social 
support for ALWH is one strategy that has demonstrated promise for supporting a successful 
transition to healthy adulthood (13–15). 
Disclosing  HIV status can refer to both “self-disclosure”, when an individual decides 
whether, when, and how to reveal one’s status to others, and also to whether someone else 
discloses an individual's status with or without their consent (16,17). The World Health 
Organization (WHO) has advocated for more support of “beneficial disclosure,” defined as 
voluntarily self-disclosing one’s status while simultaneously respecting their autonomy and self-
efficacy to do so (18). WHO has posited that the strengthening of health systems to safeguard 
HIV testing and treatment as well as increasing the protection of PLHIV from HIV stigma is a 
structural approach that would encourage increased beneficial disclosure (18). 
HIV status disclosure, as a core element of initiating social support with implications for 
psychosocial outcomes, can represent a critical juncture in the lives of ALWH. However, the 
existing disclosure literature primarily focuses on parents decisions to inform a child or 
adolescent of their status that may have been previously unknown (19–23). As such, self-
disclosure for ALWH continues to be a gap in research especially in consideration of the 
multiple complexities that may arise for ALWH considering disclosure (24,25). Adolescence is a 
time of fundamental developmental change and a desire to maintain friendships, establish a 
confident sense of self, and avoid stigma, can all shape ALWH’s choice of whether or not to 
disclose their status. The desire and expectation for autonomy among ALWH coupled with the 
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transition to adulthood and to adult HIV care creates an amalgamation of stressors that can 
severely impact their health outcomes and make the adult literature on disclosure not 
generalizable to ALWH (26). Since adolescence is also a time of sexual debut and social 
expectations to engage in romantic and sexual relationships, hesitation to self-disclose due to fear 
of diminished social cohesion and exclusion from peers can also play a major role in the spread 
of HIV (13). Nonetheless, a few limited studies have shown that self-disclosure of an HIV status 
can, in some instances, lead to positive social support for ALWH (13–15,27). Selective 
disclosure of one’s HIV status to individuals such as friends, partners, and teachers has been 
found to aid ALWH in gaining psychosocial support and adhering to ART, mitigating possible 
poor health outcomes for ALWH (28).   
Given the majority of ALWH residing in low-resourced settings, particularly in SSA (3), 
research to understand how adolescents self-disclose and what factors are related to this 
disclosure is an essential first step to helping communities support ALWH and to promote 
positive HIV treatment and psychosocial outcomes for them. Uganda serves as a model setting 
for exploring the relationship between HIV status disclosure and psychosocial factors for 
ALWH. Adolescents comprise a third of the overall population and almost half of HIV/AIDS 
cases in Uganda. While Uganda has made significant progress with the prevention of mother to 
child transmission, a high prevalence of gender-based violence and loss of breastfeeding mothers 
living with HIV from care continue to facilitate vertical HIV transmission. Despite Uganda’s 
gains in reducing HIV/AIDS transmission and mortality rates, a high proportion of new 
infections are occurring among adolescents (29,30) who remain highly vulnerable due to 
engagement in high-risk sexual behavior and substance use (31). Uganda has had great success 
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in widescale provision of ART, but adherence among ALWH remains a challenge due to poverty 
and stigma (32,33) .  
Few studies from Uganda have explored the associations between mental health and self-
disclosure of HIV status among ALWH (11,14,34). Of those that do, disclosure of HIV status 
was found to be both positively and negatively associated with mental health.  Whereas self-
disclosure in this setting resulted in both internalized and enacted stigma leading to poor mental 
health, it also has led to familial support that enabled resisting stigma and adverse psychosocial 
outcomes (11,14).  The importance of being able to talk with a caregiver about HIV has also 
been found to be associated with comfort in disclosing one’s status and coping with an HIV 
diagnosis in Uganda (34) . Furthermore, a study with ALWH, their caregivers, and health 
workers in Uganda emphasized the need for better support in preparing ALWH to self-disclose 
as it was a salient challenge related to their sustained healthcare given subsequent psychosocial 
challenges that could emerge post-disclosure (34).  
Given the limited evidence as to the implications of HIV status disclosure on 
psychosocial outcomes for ALWH in Uganda, this study examines the relationship between self-
disclosure and mental health outcomes for adolescents in this setting. We sought to characterize 
to whom ALWH chose to disclose, what sociodemographic factors were associated with this 
disclosure choice, and how the individual disclosed to was associated with depression and 
anxiety. Findings from this study can be used to inform future initiatives that support and prepare 
ALWH to self-disclose their HIV status. 
4.3 Methods 
 
Study Population and Data Collection 
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This study is a secondary data analysis of the Pediatric HIV/AIDS Research Project 
(PHARP). PHARP recruited adolescents (aged 11-18 years) from Uganda to understand 
differences in functional outcomes between three cohorts of participants: ALWH who were 
perinatally infected, adolescents who were exposed to HIV in utero but who were uninfected, 
and HIV-negative adolescents unexposed to HIV in utero. Participants were recruited from the 
database of patients currently receiving ART through the Kawaala Health Center in Kawempe, a 
division of Kampala. Eligibility for the parent study was limited to adolescents who were born in 
a hospital setting in order to verify HIV status and post birth clinical history, (i.e., those who 
were perinatally infected). Participants without an official birth record and/or antenatal register 
and delivery records were excluded. Between October 2018 and January 2020, caregivers of 
ALWH were contacted via telephone or approached when in the waiting area of the clinic to 
learn about the study. If caregivers were interested, they were asked to provide written informed 
consent and adolescents must also have provided assent to be included in the study. All 
participants enrolled in the study were followed for a period of 12 months starting October 23rd, 
2019 through January 20th, 2020 with study surveys administered in Luganda by trained research 
assistants to adolescents (and caregivers) every 4 months. For the purposes of this analysis, we 
restricted to only ALWH who were perinatally infected (n=157). We further excluded 
adolescents who reported not taking a daily medication, followed by those who did not know the 
reason why they were taking a daily medication (e.g., ART for HIV), and finally adolescents 
who did not report HIV/AIDS as the reason for medication use as we did not want to 
inadvertently disclose their HIV status to them. Given this, only the subsample of perinatally 





This secondary data analysis draws from only the baseline data collection conducted in 
PHARP. The baseline survey included collection of the following demographic variables 
relevant to this study: age (11-18 years), sex (female or male), and education status (years of 
education). Adolescent age and sex were confirmed via birth records.  
HIV Disclosure. The specific survey questions regarding disclosure in the parent study 
asked with whom an ALWH had chosen to share their HIV status. HIV disclosure was assessed 
by first asking ALWH whether they had self-disclosed their HIV status to anyone, and for those 
who had disclosed, to which of the following ten categories of individuals they disclosed their 
HIV status: spouse or steady sexual partner; mother; father; sister(s); brother(s); child; other 
female relative(s); other male relative(s); friend(s); or, other. Adolescents indicated a binary 
response of yes/no for each category. Other female or male relatives were individuals not 
included in one’s nuclear familial unit, e.g., an aunt, uncle, cousin, niece or nephew. The “spouse 
or steady sexual partner”, “child”, and “other” variables were excluded from this analysis since 
each was uncommonly endorsed by study participants (<8%). For the purpose of this analysis, 
we examined HIV status disclosure in three ways: 1) any disclosure; 2) number of disclosure 
categories (by summing across the 7 disclosure options used in this study); and 3) specific 
disclosure choice among the four most common parties disclosed to in this sample. 
Mental health. Mental health outcomes were measured using the Behavior Assessment 
System for Children (BASC-3). The BASC-3 was chosen for this study given its neurological 
and cognitive measurement properties and inclusion of externalizing problems, internalizing 
problems, and adaptive skill measures (35). This measure was adapted for cultural context by the 
PHARP study team and forward and backward translated between English and Luganda. For the 
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purpose of this study, we focused on internalizing symptoms. The BASC-3 generates separate 
scores for anxiety (13 items) and depression (12 items), which for this study were standardized 
by age and sex using the HIV unexposed and uninfected adolescent cohort in Uganda as a 
reference population and are presented as continuous z-scores. The Cronbach’s alpha for internal 
consistency for the depression and anxiety scales were both 0.74.  
Statistical Analysis  
Descriptive statistics were calculated to assess the prevalence of self-disclosure to 
different individuals. Chi-square test of independence for categorical variables and one-way 
ANOVA were conducted to compare differences in sociodemographic characteristics by status 
of self-disclosure to mother, father, sister(s), brother(s), other female relative(s), and other male 
relative(s), or friend(s). Multiple linear regression was then used to explore the associations 
between disclosure variables and z-scores for depression and anxiety. The top four disclosure 
choice variables with the highest responses among ALWH, number of disclosure categories, and 
any disclosure were modeled as the independent variables with depression and anxiety as the 
dependent outcomes in six separate, unadjusted models (Model 1 for each disclosure outcome). 
These models were then adjusted for the number of disclosure categories (Model 2). Age 
(continuous in years), sex (female, male) and education (not in school, in school) were added to 
the final models (Model 3). 
All analyses were performed using Stata Version 15.1 (36). All statistical tests were 
performed at an alpha of 0.05. The study was approved by the research ethics review committees 
of Michigan State University (IRB Protocol#: 16-828), Makerere University College of Health 
Sciences, School of Medicine (Protocol REC REF# 2017-017) and the Uganda National Council 
for Science and Technology (Protocol #: SS 4378). This secondary analysis of deidentified data 
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was exempted by the Johns Hopkins University Bloomberg School of Public Health Institutional 
Review Board.  
4.4 Results 
 
 87 ALWH were included in analyses (Table 4.1). The overall mean age of participants 
was 14.70 years with approximately 60% being female and a third not currently in school. The 
average depression z-score was 0.32, and for anxiety was 0.16, i.e., they were 0.32 and 0.16 
points over the mean age/sex standardized score of adolescents unexposed and uninfected with 
HIV on average. Over 70% of the adolescents had disclosed their HIV status to at least one 
individual. 
Table 4.1. Sociodemographic Characteristics of ALWH (n=87)  
 Total  
(n=87) 
Age in Years, mean (sd) 14.70 (2.29) 
Female, n(%) 51 (58.62) 
Not in School, n(%) 29 (33.33) 
Depression Z-Score, mean (sd) 0.32 (1.34) 
Anxiety Z-Score, mean (sd) 0.16 (1.03) 




Figure 4.1 provides an overview of the different types of people to whom ALWH 
reported disclosing their HIV status. Almost two-thirds of ALWH (63%) had disclosed their 
status to their mother. The next individuals ALWH most frequently disclosed to was their father, 
sister(s), or brother(s), with over 50% indicating that they had disclosed to each. Other female or 
male relative(s) were less often disclosed to, with only 32% of participants reporting having 
disclosed to other female relative(s) and 29% to other male relative(s). Those least disclosed to 
were ALWH’s friends, with only one-fifth of participants having told at least one friend about 
their HIV status. Similar patterns were observed for disclosure by participant sex. Both females 
and males had the same top four categories of individuals they disclosed to: their mother, father, 
sister(s), or brother(s). Females adolescents disclosed to anyone more frequently and to all 
categories of people as compared to male adolescents, including to their brother(s) and male 
relative(s) (Figure 4.2).  




Figure 4.2. Frequency of Disclosure by Sex (n=87) 
 
Sociodemographic Characteristics and Self-Disclosure Patterns 
Table 4.2 presents sociodemographic characteristics and mental health outcomes by 
disclosure choice. The only statistically significant difference observed when examining an 
adolescent’s age and who they disclosed to was for other male relative(s) (mean age among those 
who disclosed=15.5 vs. mean age among those who did not disclose=14.3, p=0.03). In addition, 
ALWH who were in school had greater prevalence of disclosing to both a female and male 




Table 4.2. Differences in Sociodemographic Characteristics and Common Mental Disorder Symptoms by Disclosure of Status among 
ALWH (N=87) 
 






























Age, mean (sd) 14.65 (2.35) 14.90 (2.15) 14.67 (2.35) 14.83 (2.21) 14.90 (2.27) 14.64 (2.27) 14.78 (2.37) 14.56 (2.23) 15.29 (2.27) 14.40 (2.27) 15.52 (2.26) 14.34 (2.26) 15.65 (2.32) 14.49 (2.26) 
P-valuea 0.63 0.74 0.61 0.66 0.10 0.03* 0.07 
Female, n(%) 32 (58.18)  18 (58.06)  27 (56.25)  22(61.11)  28 (58.33)  21 (58.33)  23 (51.11)  27 (65.85)  14 (50.00)  36 (63.16)  15 (60.00)  35 (59.32)  12 (70.59)  37 (56.92)  
 




























28 (43.08)  
       P-valuea 1.00 0.82 1.00 0.19 0.35 1.00 0.41 
 



























8 (47.06)                       
 
46 (70.77) 
Not in school, n (%) 18 (32.73) 10 (32.26) 17 (35.42) 11 (30.56) 19 (39.58) 8 (22.22)  18 (40.00)  11 (26.83)  14 (50.00)  15 (26.32)  14 (56.00)  14 (23.73)  9 (52.94)  18 (27.69)  
P-valuea 1.00 0.65 0.16 0.25 0.03* 0.01* 0.08 
Depression, mean 
(sd) 
0.21 (1.23)  0.52 (1.55)  0.15 (1.30)  0.55 (1.44)  0.15 (1.27) 0.56 (1.48)  0.10 (1.16)  0.57 (1.51)  0.41 (1.13)  0.27 (1.46)  0.37 (1.16)  0.29 (1.45)  0.62 (1.27)  0.24 (1.41)  
   P-valuea 0.32 0.18 0.18 0.11 0.66 0.81 0.32 
Anxiety, mean (sd) 0.16 (1.12)  0.14 (0.86)   0.09 (1.17)   0.23 (0.85)  0.11 (1.08)  0.21 (0.94)  0.09 (1.18)  0.24 (0.86)  0.25 (1.05)  0.11 (1.04)  0.18 (1.01)  0.11 (1.05)  0.30 (1.02)  0.09 (1.05)  
  P-valuea 0.91 0.56 0.68 0.50 0.56 0.79 0.47 
 




Self-Disclosure Patterns and Mental Health Outcomes  
Results of linear regressions testing associations between any disclosure, number of types 
of individuals to whom an ALWH self-disclosed, and self-disclosure to each of the top 4 most 
frequently self-disclosed to type of individuals are presented in Table 4.3. In the fully adjusted 
model, any disclosure was significantly associated with lower depression z-scores (β= -0.51, 
CI=-1.12, 0.11). Any disclosure was also associated with lower anxiety z-scores in the fully 
adjusted model, but this was not significant (β=-0.09, CI=-0.59, 0.41). The number of types of 
individuals an adolescent reported self-disclosing to was non-significantly associated with lower 
depression (β= -0.08, CI=-0.19, 0.04) and anxiety z-scores (β= -0.02, CI=-0.11, 0.07) in the fully 
adjusted models. Self-disclosure to one’s brother(s) versus non-self-disclosure to this type of 
individual was significantly associated with lower depression z-scores (β= -1.02, CI=-2.00, -
0.05) in the fully adjusted models.  Self-disclosure to one’s father (β= -0.46, CI=-1.54, 0.62), 
sister(s) (β= -0.66, CI=-1.68, 0.36), and mother (β= -0.05, CI=-0.97, 0.87) were similarly 
negatively associated with depression z-scores in the fully adjusted models, but none of these 
associations reached statistical significance. Similar non-significant negative associations were 
found for anxiety, except that disclosure to mothers exhibited a non-significant positive 




Table 4.3. Linear Regression of Mental Health Outcomes on Disclosure of HIV Status among ALWH (N=87) 
Depression Anxiety 
 Model 1a Model 2b Model 3c Model 1a Model 2b Model 3c 





















































































a  Unadjusted model 
b Adjusted for number of categories of people an adolescent indicated disclosing to 








This exploratory study sought to understand to whom ALWH in Uganda self-disclose 
their HIV status, any potential differences among ALWH in who they chose to disclose to, and 
the association of disclosure choices with anxiety and depression. Most adolescents had self-
disclosed their HIV status to at least one person, and those adolescents reported lower depression 
and anxiety z-scores, with a significant association observed only with depression. Despite 
mothers being the most frequently mentioned person an adolescent had self-disclosed their HIV 
status to across participant demographic categories, the association between disclosure to 
mothers and both depression and anxiety symptoms was non-significant.  
 Few studies have examined associations between HIV status self-disclosure and mental 
health among ALWH in SS A(37). Disclosure among one’s family being generally non-
significantly associated with these symptoms (with the exception of disclosure to brothers and 
depression symptoms) in our study contradicts a recent study from Kenya in which disclosing to 
family members versus non-family members resulted in marginally higher depressive symptoms. 
However, this study did not differentiate between nuclear family and extended family members 
(37). Regarding our findings, it is worth considering that the potential beneficial outcomes 
associated with disclosing to one’s nuclear family compared to their extended family or friends 
may be a reflection of the close-knit environment within which ALWH live their daily lives. 
Studies that have found family cohesion being associated with HIV disclosure among adults, 
perhaps reflect greater trust and connectedness within the family (38). In close-knit families or 
families living in close proximity, it is also possible that nuclear family members are more likely 
to be or become aware of an adolescent’s HIV status, as it can be harder or almost unavoidable 
in these conditions to maintain the secret of one’s status (39). This may make self-disclosure 
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inevitable or less impactful as studies have demonstrated that ALWH may feel a lack of control 
when families know their status and exert control over when and to whom they are allowed to 
disclose to (40).    
While it might be assumed that mothers already know the HIV status of their perinatally 
infected children, adolescents in this study were asked who they had told about their status, with 
further clarification of who specifically had they chosen to share their HIV status with provided 
by the research assistant and as detailed in the study survey. Therefore, our findings may reflect 
and adolescent’s choice to voluntarily engage with relatives including their mothers about their 
HIV status, even if assumed they may already know. Our finding that mothers were the most 
disclosed to type of person coincides with the literature on HIV status disclosure (37,41).  
However, more research is needed to understand the implications of this broadly for ALWH. Our 
findings indicate the possibility of poorer psychosocial outcomes associated with disclosing to 
one’s mother in the case of anxiety, though results are non-significant and can only be 
interpreted as suggestive and exploratory. This could stem from the fact that should an ALWH 
disclose to others about their status, it can indicate a mother’s HIV status as well, placing 
unwanted burden on them. This can create familial stress that compounds poor mental health for 
ALWH (13). It has also been found that while ALWH may want to self-disclose, negative 
parental attitudes about this prevent them from doing so which can lead to stressors such as 
isolation and feeling lonely (42), which correlate with depression and anxiety (43).  
Our results showed disclosure to peers was uncommon among both youth in and out of 
school and among both females and males. The fear of being rejected by friends or having 
friends share one’s HIV status without their consent is a commonly cited reason for ALWH not 
disclosing their status to peers (13,14,44). Our findings also did not show that ALWH who had 
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disclosed to peers experienced any significant association with mental health symptoms. Of note, 
prior studies that have found diminished social support from peers upon disclosure (45) and 
increased mental health difficulties. Conversely, one study found that disclosure to close friends 
was not associated with distress, while disclosing to acquaintances was (46). Participants in our 
study may have collapsed friends and acquaintances in responding and there may be subgroups 
of ALWH who experience positive versus negative reactions from friends. This suggests the 
need for qualitative studies specifically focused on disclosure to peers that can provide more 
nuanced insight as to how decisions to disclose to different types of peers may be made and how 
these different types of disclosure may be differentially understood to be related to overall 
psychosocial wellness, positively or negatively. Even less is known about the negative effects of 
disclosure to a non-nuclear family member, even though our study found disclosure to these 
individuals to be more common than peer disclosure. Relatives such as aunts have also been 
found to provide support to ALWH (28), yet there is a scarcity of research in which to 
contextualize our findings on relatives and possible worse mental health scores.  
While patterns in who was most commonly disclosed to were similar by adolescent sex, 
female ALWH disclosed more frequently across all categories of individuals than male ALWH, 
including to male family members. Evidence is currently limited as to what differences may exist 
among female versus male ALWH in self-disclosure of HIV (10). An existing study from 
Uganda found lower levels of disclosure from female adolescents as compared to males (10), 
unlike in our study. Reasons for having observed lower disclosure among females in other 
studies from SSA have been hypothesized as their experience of greater social and economic 
vulnerability and greater fear of being rejected by others (47,48).  However, previous literature 
on ALWH in Uganda specifically found female adolescents communicate more and in turn 
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receive more social support then their male counterparts (49), which coincides with our finding 
and may suggest something unique about the Ugandan context deserving of further in-depth 
exploration. 
Our exploratory findings point to the need for a multi-method study as to the reasons 
ALWH choose to disclose to particular individuals in a larger population in order to confirm 
patterns seen in this assessment. Reliance on only quantitative findings does not allow for 
understanding the decisions behind choice of disclosure for ALWH and understanding across a 
variety of sociodemographic is integral to having a more comprehensive view of adolescents in 
Uganda. Research as to the poorer mental health outcomes for those who disclosed to relatives 
outside of the immediate family is especially needed given that ALWH may be cared for by 
these individuals at some point in their lives (50). In addition, extant literature calls for better 
support for ALWH to self-disclose and to be equipped with better capacity to assess who to 
disclose to and ways to cope with negative outcomes of disclosure (18). Our findings point to 
these efforts being targeted among the immediate nuclear family with whom ALWH are most 
likely to live. Future research should ask ALWH who they would want to disclose to, why they 
seek to disclose to those individuals specifically (with a focus on perception of existing 
knowledge of their status included), and what characteristics are important in assessing to whom 
to disclose.  
Furthermore, it is important to consider the general difficulty in assessing self-disclosure 
of HIV status to mothers in perinatally infected populations. ALWH may not be aware that their 
mother knows their HIV status and upon self-disclosing to them, are initiating a discussion about 
HIV for the first time. Future studies should consider asking an ALWH who disclosed their HIV 
status to them, with whom they have specifically engaged about their HIV status through self-
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disclosure, and if an individual lists their mother as knowing their status prior to their self-
disclosure or despite having not disclosed. It may also be important to assess if when an 
adolescent self-discloses to anyone their status, whether or not they assumed that individual 
already had knowledge of their status or not. In addition, given the potential associations seen in 
this exploratory analysis between self-disclosure choices and mental health, these choices require 
further examination in conjunction with adherence. Disclosure choice may be predictive of 
adherence patterns, given the evidence as to positive social support leading to better sustainment 
of HIV treatment (51).   
 
Limitations 
 This study and its findings should be considered in light of several limitations. We 
consider this study exploratory as this was secondary analysis and this analysis was not powered 
to look conclusively at relationships explored. In addition, we acknowledge that there is 
significant heterogeneity in experiences within the adolescent developmental period that this 
study is unable to parse out due to its small sample size. We looked for differences between age 
groups defined as younger (10-14) and older (15-18) (52,53) and did not observe meaningful 
differences which could also be due to said sample size. We therefore chose to consolidate age 
groups for this study to preserve sample size. In addition, we acknowledge that studying a group 
of adolescents in Uganda means we are understanding disclosure and mental health within a 
specific cultural setting(s). Future studies should explore the culturally specific nuances of 
disclosure and mental health for this population. Adding to this point about culture and, also 
given that we have a clinic sample, both factors limit generalizability to participants recruited 
from the community and from varying cultural backgrounds. Of additional importance, ALWH 
exhibiting higher levels of depression and anxiety may have been less likely to be engaged in 
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care and thus to have enrolled in our study. Furthermore, the mental health measure used in this 
study, the BASC-3, has not been validated in Uganda and thus it is possible that important 
aspects of mental health are not captured in its use. However, careful attention was paid to the 
adaptation and translation of this measure for use in this population. It is possible that one’s 
mental health influences one’s choices to disclose rather than disclosure leading to different 
mental health outcomes. ALWH who are also exhibiting poor mental health may be less likely to 
disclose to anyone compared to those who are less impacted psychosocially and longitudinal 
study to confirm this is required. We were also unable to assess the exposure of self-disclosing 
one’s HIV status and the time to develop mental health symptoms, which is deserving of future 
study as there may be critical windows of exposure as it relates to psychosocial impacts.  
4.6 Conclusion 
 
Our study adds knowledge to the literature from SSA on individual choice by an ALWH 
on to whom to self-disclose their status and possible associations of these different choices with 
mental health. Specifically, we explored nuances about choice in HIV status self-disclosure not 
typically captured in studies by including a wider range of disclosure choices than what has been 
studied in SSA among adolescents. Our findings of lower depression symptoms associated with 
self-disclosing HIV status to anyone versus no one and disclosing to a brother(s) versus no one 
highlight possible psychosocial implications of selective self-disclosure to specific individuals by 
ALWH. As both rejection and support can stem from self-disclosure, it is essential to first 
understand who ALWH are disclosing to and how it is related to mental health to begin to parse 
helpful and harmful reactions to disclosure and begin to target future research and intervention 
efforts aimed at increasing social support for ALWH. As ALWH are developing increasing 
independence during this major developmental time, a sole focus on understanding disclosure of 
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an ALWH’s HIV status to them from someone else in lieu of attention to self-disclosure, 
undermines ALWH’s autonomy and ultimately understanding of how to best support their 
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 Chapter 5: “It’s better if I die because even in the hospital, there is a stigma, 
people they still gossip”: The Impact of Gossip as Stigma for Persons Living 
with HIV in Botswana 
5.1 Abstract 
 
Introduction: In 2002, Botswana became the first country in sub-Saharan Africa to offer 
universal access to antiretroviral therapy. Yet, Botswana continues to have a high prevalence of 
HIV. Despite universal access, uptake of HIV testing and treatment remain below global targets, 
suggesting a strong influence of social and cultural factors in impeding treatment. This study 
specifically advances this area by analyzing cultural aspects of stigma as gossip among PLHIV 
in Botswana. 
Methods: A total of 5 focus groups and 46 in-depth semi-structured interviews were conducted 
in Gaborone, Botswana in 2017. Each focus group and interview comprised of either individuals 
living with HIV or general community members for whom we did not ask about their HIV status. 
Focus groups and interview transcripts were assessed using a two-step directed content analytical 
approach and subsequent inductive thematic analysis. 
Results: Results indicated that gossip regarding one’s HIV status can diminish one’s community 
standing and lead to poor psychosocial outcomes and non-adherence to ART. Additionally, 
gendered vulnerabilities to stigma suggest women and men experience differential harmful 
outcomes. Of equal importance is the emergence of data revealing protective factors that mitigate 
if not reverse stigma such as appearing healthy, accepting one’s HIV status, and having a 
mediator to help educate those who gossip. 
Conclusions: This study advances the literature on HIV stigma by outlining how gossip operates 
among PLHIV in Botswana as both a mechanism for stigma and a type of stigma in of itself. 
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Results are informative of the ways in which research and practice should incorporate support for 
PLHIV to resist and cope with gossip.     
5.2 Background 
 
Decades of biomedical research and intervention related to the advent and widespread 
implementation of HIV antiretroviral therapy (ART) have curbed HIV transmission and 
prolonged the lives of people living with HIV (PLHIV). However, progress in addressing 
psychosocial factors that shape the HIV epidemic has been slower, and these factors continue to 
hinder HIV prevention and treatment efforts globally(1). HIV stigma is one such psychosocial 
factor that can severely limit health seeking behaviors and treatment adherence, in addition to 
perpetuating poor mental health outcomes for PLHIV(1,2) . HIV stigma refers to processes that 
devalue PLHIV through labelling and enacting subsequent discrimination or exclusion at the 
individual, societal, and structural levels (3). Importantly, stigma can also be experienced by 
PLHIV as the perception or anticipation of maltreatment and as the internalization of negative 
thoughts, attitudes, and behaviors(4). 
In 2002, Botswana became the first sub-Saharan African country to provide universal 
access to HIV treatment, and it remains an exemplar of national response to the epidemic (5). 
Yet, Botswana continues to have the 4th highest prevalence of HIV in the world (6,7). Given the 
long history of universal access to care, Botswana provides a unique setting for contextualizing 
HIV stigma as a barrier to nonadherence, as resources are not a primary impediment to accessing 
treatment(5). Previous studies in Botswana have demonstrated how stigma is felt most acutely by 
PLHIV when it keeps individuals from being a respected and valued member of society, 
effectively preventing the achievement of full personhood (8,9). Since notions of personhood are 
gendered in Botswana(9,10), by association the nature and experience of HIV stigma is also 
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gendered. For men, a positive HIV status threatens masculinity by fostering perceptions that they 
are incapable of fulfilling the role of provider for their families on account of discrimination they 
could face, particularly regarding both getting and keeping employment(8,9). Women were also 
found to bear a disproportionate burden of HIV stigma due to antenatal care policies requiring 
HIV testing during pregnancy. These policies often lead to women being the first identified in a 
relationship as living with HIV, which results in women being blamed for its transmission (9).  
Extant literature from Botswana is suggestive of gossip operating as both a mechanism of 
labeling individuals as living with HIV and being a form of stigma in of itself (8,9). Among 
existing studies that touch on gossip and HIV, gossip has been shown to be a common form of 
enacted stigma for PLHIV. Studies also find that gossip is largely not focused on blaming 
PLHIV for the spread of HIV, but rather used to center the actions of PLHIV as to blame for 
their own HIV infection, such as labeling women living with HIV as promiscuous (9,11). While 
this prior research suggests that gossip about HIV in Botswana can lead to differential outcomes 
by gender and precipitates poor psychopathology (8,9,12), the mechanisms by which gossip 
about HIV engenders or acts as a form of HIV stigma have yet to be explored.  
 Broadly, gossip is considered a major public health challenge in its own right, given its 
impediment to prevention, diagnosis, and treatment of health conditions (13–15). Gossip has 
been described as a means of distinguishing between groups of people: those who fulfill societal 
expectations and those who do not (16). Gossip may therefore serve to label PLHIV, which then 
allows them to be subjected to stigma, when a PLHIV’s status is inferred or assumed based on 
the observation of specific behaviors or characteristics. Gossip has also been conceptualized as a 
means of social control, or an approach by which to maintain cultural and social norms when an 
individual or their behaviors are appraised as threatening to those norms (16). Fear of gossip has 
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been found to be pervasive among PLHIV and to prevent them from seeking clinical care and to 
be a salient reason for choosing not to self-disclose (17,18).  
Yet, few studies have focused exclusively on clarifying how gossip operates in public 
health, particularly as it relates to PLHIV. This study seeks to advance the understanding of 
gossip as a labelling process and vehicle for stigma among PLHIV in Botswana. Through 
application of the What Matters Most (WMM) theoretical framework that elicits core aspects of 
personhood among individuals within specific cultural settings as a means of understanding 
stigma, we examine gossip as HIV stigma within Setswana culture (19). In addition, we explore 
the ways in which gossip can undermine or interfere with biomedical prevention and treatment 
approaches designed to control the epidemic in the Botswanan context. We strive to elucidate the 
process and impact of gossip and use this to necessitate a biopsychosocial approach to addressing 




In 2017, participants were purposively sampled for 5 focus groups (FGs) of 5-6 
individuals each or 46 in-depth semi-structured interviews (IDIs) in Gaborone, the largest city 
and capital of Botswana. Our purposive sampling strategy aimed to recruit a balance of men and 
women, as well as both PLHIV and individuals for whom we did not ask their HIV status to 
facilitate understanding of HIV stigma from the perspectives of those with lived experience with 
HIV and the general community. Participation was limited to adults aged 18 or older living in 
Gaborone, with additional eligibility criteria for PLHIV being that they were currently receiving 
clinical care for HIV, and for individuals whose HIV status was unknown to researchers, being 
willing to discuss HIV stigma. Participants living with HIV were recruited from a large public 
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hospital with specialty HIV clinical care services. Individuals from the general community (i.e., 
HIV status unknown) were recruited from Main Mall in Gaborone, a central plaza within the 
city. All participants were given a choice as to whether they wanted to participate in either a FG 
or IDI, as well as if they preferred the use of Setswana (i.e., the local language) or English.  
Written informed consent was obtained for all participants, and they were compensated 
50 pula (~$5 US) for their travel. Approval for this study came from the Institutional Review 
Boards of the Botswana Ministry of Health and Wellness, University of Botswana, Princess 
Marina Hospital, University of Pennsylvania, Columbia University, and New York University. 
Data Collection and Procedures  
Data collection and procedures have been previously described elsewhere (9,20). WMM 
was used as the framework for this study as its purpose is to make explicit the salient activities 
and cultural values integral to one’s daily life that interact with how stigma is experienced in a 
specific cultural context. The framework further facilitates exploration of cultural capabilities 
that serve as risk and protective factors for HIV stigma(19,21,22). Semi-structured FG and IDI 
guides were designed based on this framework and its implementation in prior studies (19,23) 
examining the cultural underpinnings of stigma. The questions were modeled to cover the 
domains and topics represented in the Devaluation-Discrimination Scale (DDS) but retooled to 
be open ended (24). Both guides consisted of six original questions from the DDS and then four 
culturally and contextually specific interview items for the purposes of this specific study’s aims 
(Appendix C). One item elicited factors that enabled HIV identification and subsequent stigma 
(“When does a woman/man typically find out that they are HIV positive?”), two items 
specifically asked about aspects integral to personhood (“What does it mean to be a proper man 
(or woman) in Botswana?”; “Does having HIV affect a proper man (or woman’s) status?”), and 
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the last of the four items asked about the role of gossip in Setswana culture (“Does gossip effect 
a person with HIV’s ability to be a good Batswanan?”). In addition, participants could and did 
spontaneously express examples of WMM in Setswana culture across all items. 
 The use of FGs was intentional to elicit cultural norms associated with HIV stigma in this 
setting. IDIs were then used to obtain more nuanced understandings of these norms. Therefore, 
FGs were conducted first and separately among women and men living with HIV and separately 
among women and men from the general community. The FG guides were iteratively modified 
throughout data collection to refine questions in order to capture emergent themes expressed by 
participants. FGs were co-facilitated and IDIs were independently conducted by 4 bilingual 
Setswana research assistants from Gaborone and 1 Ghanaian American research assistant, who 
conducted the interviews solely in English. FGs were facilitated by the Principal investigator in 
partnership with a Setswana research assistant. Each FG group ranged from 60-120 minutes in 
duration. Subsequently, IDIs were conducted by the 5 research assistants. As with the FG guides, 
IDI guides were iteratively updated throughout the course of data collection to explore emerging 
themes in greater depth and to build upon the information elicited. IDIs were of 60-90 minutes in 
duration. Both FGs and IDIs were audio recorded and simultaneously transcribed and translated 
to English if a session was conducted in Setswana.  
Data Analysis 
The data analysis for this study was conducted in two phases. During the first phase, 
initial coding of transcripts involved a two-step directed content analytical approach using word 
processing software; codes were organized into categories using spreadsheets. The first step in 
the coding process was deductive and consisted of operationally defining coding categories 
informed by categories from prior qualitative work in other settings by the Principal Investigator 
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that had also drawn on the WMM framework to understand stigma. The categories were the 
following: 1) cultural capacities necessary to fulfill womanhood or manhood, 2) how WMM 
shapes stigma, 3) the ability of fulfilling WMM to protect an individual from stigma, and 4) 
structural vulnerabilities to inform how the intersection of structural factors and “what mattered 
most” in Setswana culture led to marginalization of PLHIV. The first step was completed by 
having two sets of coding teams each apply codes to two FG transcripts and then present their 
findings to one another over six meetings to conceptualize operational definitions for each 
category that became the basis for the study codebook. The resultant codebook was then used by 
four pairs of coders to highlight participant descriptions of mechanisms of HIV stigma as it 
related to fulfilling obligations expected of an individual within the Setswana culture in all of the 
remaining FG and IDI transcripts. Each coding pair coded transcripts separately, but then would 
meet to address and resolve discrepancies. Each coding team then presented their findings to the 
entire study team during weekly 60-minute calls over the course of 18 months (~70 meetings). 
New codes were adapted and added to the codebook for use by all coding teams throughout these 
meetings based on emergent findings.  
The second step of this initial coding scheme was the inductive elucidation of the 
relationships between categories to understand how the intersection of structural factors and 
“what mattered most” in Setswana culture led to marginalization of PLHIV. A sub-team met 13 
times (~26 hours) to discuss the conceptualization of these relationships and presented their 
conclusions to the entire study team after having reached consensus, with further refinements 
made based on the full study team discussion.  
The first phase of data analysis for this study had an intentional gendered focus, yet 
gossip emerged as a cross-gender theme stemming from the category WMM shapes stigma. 
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Based on our findings from this first phase and building off the aforementioned coding approach, 
we completed a second phase of coding for the purposes of this manuscript: to specifically 
examine the ways gossip generates and operates as stigma in this sample. A team of four coding 
pairs each individually re-coded the FG and IDI transcripts using an inductive thematic analysis 
approach. The entire coding team met 4 times (~8 hours), with each pair presenting their 
emergent themes. During these meetings, themes were modified to reach consensus among all 
team members as to how to contextualize the role of gossip in Setswana culture as it pertains to 
HIV.  
It should also be noted that throughout the data analysis, consideration was taken as to the 
potential for different themes to emerge from FGs versus IDIs since they garner different forms 
of information. Throughout the coding process, coding teams compared emergent themes arising 
from data collected via both methods to assess for divergences. Through the iterative coding and 
re-coding of all transcripts, this study was able to thoroughly assess whether there were evident 
differences. Given these comparisons, it was concluded that themes did not substantially vary 






A total of 84 participants (n=43 women and n=41 men) completed either a FG (n=38: 
n=20 women; n=18 men) or IDI (n=46: n=23 women; n=23 men). Demographic characteristics 
of participants who contributed data to this analysis are presented in Table 5.1. More than half 
(n=45) of participants were individuals who reported living with HIV. For women, the mean age 
was 42.2 years, the majority had at least completed secondary school, and almost half were 
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unemployed. For men, mean age was slightly younger than women (41.4 years), the majority had 
completed at least secondary school, and under one-third (30%) were unemployed. The majority 
of men (46.4%) and women (55.8%) reported being single, i.e., not in a relationship. 
Gender Dynamics of Setswana Culture and their Intersection with HIV   
 Gossip was experienced across both genders in the sample. However, as the sociocultural 
roles of men and women are different, the content and drivers of gossip were different. For 
women, being a mother is expected, ascribes status, and is fundamental to being regarded as a 
respected woman in Setswana culture. Being a mother is also associated with an expectation that 
a woman will remain home and care for others. Female participants explained how not meeting 
these roles could lead to gossip about your ability to be a woman in the eyes of others.  
…a proper Motswana woman is also judged, the way she is seen in the community, is 
reflected by the way she takes care of her own children, especially bathing them, 
making sure they have food, and they go to school… she has to be very faithful, and take 
care of the children - IDI, man, living with HIV 
They [community] will gossip, ‘you are a barren woman, you don’t bear children, you  
are like a bull in a kraal [your purpose is to bear children], but you are a woman - IDI, 
woman, living with HIV 
 
We take it that a woman belongs to the home, so we wonder if she has HIV [if seen 
with others outside of the home], there is no woman in her. She is a whore, there is no 
woman-IDI, man, living with HIV 
 
Men also described culturally specific expectations that must be met to be afforded respect 
within society, including being able to provide for their families. Failing in these roles led to 
questioning a person’s capabilities as a “real man” in Setswana culture.  
A real man is the one who is employed, ensures that his children are well fed, hygiene 
taken care of, clothed well, ensures that the wife is taken care of, even doing farming. 
[He] should be married-IDI, woman, living with HIV 
 
A real man should be seen as also carrying out the home duties. By rearing cattle, 
rearing goats, be a Motswana man. A Setswana man should be seen by the cattle he 
owns. And his home, taking care of his home…having cleared the yard and cutting the 
trees, making a good fireplace. Those are the things that a real man will be praised for. If 
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those things are missing, then you should know there is no real man in that home. -
IDI, man, living with HIV 
 
The inability to fulfill one’s male duty to be a provider could elicit stigma for any man. 
However, in order for a man living with HIV to be successful, it was also imperative that he 
conceal his HIV status to avoid gossip which could hinder his success by not receiving job offers 
or opportunities to further advance himself.  
It is [possible for an HIV+ man to be successful] but most of them keep their statuses to 
themselves to avoid rumors. If other people know your status in the community, it is 
very hard to be successful as maybe employers will be reluctant to offer you jobs or 
tenders. So the best way is to keep it to yourself. - FG, man, unknown HIV status 
 
Gendered Engagement in Gossip 
Participants also described gendered notions about who enacts gossip. For women, there 
was a clear line between who does and does not gossip, and that they are the ones who perpetrate 
gossip.   
Even in the Bible, a woman gossips, but sometimes a woman can gossip about 
something that is geared towards the truth. Men don’t gossip. He will face you and 
burst at you, “you see, I don’t like PLHIV”, but women will say, “apparently that woman 
is living with HIV, she is not good”- IDI, woman, living with HIV 
 
Women also had little power to combat gossip spread about them by men or other women, 
especially when it came to HIV. 
 
As a woman if I’m sleeping around, I’d be called a slut but then it’s different in that 
men, they can sleep around, but then the responsibility would be on the woman that 
she is the one who is at fault. His family are the ones who are going to say that I am the 
one who gave him HIV - IDI, woman, unknown HIV status  
 
Gossip among men, however, was not expected and even described as violating social support 
that men are expected to provide to one another. It was also pointed out that men consider gossip 
from women to be trivial, as women were generally thought to engage in talk about others (while 
men were not).  
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When a man is being gossiped by other men it is not good because as men we believe 
that men are supposed to be supportive to the other man so if now the men are the 
ones who are gossiping about you, it’s really not acceptable and it’s not good at all. But if 
a woman gossips about other man, women are like that. Even in the society we know 
that women are people who talks too much so we accept it. Of course, it felt like 
losing status, if man gossips - IDI, man, HIV status unknown  
 
Men’s social standing was most threatened when other men gossiped about them, yet this was a 
rarity as gossip among men was seen as atypical, while women could face severe consequences 
stemming from both men and women discussing their behaviors. 
Precipitators of Gossip  
 
The majority of participants agreed that there were particular behaviors that could lead to 
gossip about one’s HIV status. Being seen at the infectious disease clinic or taking medication 
were especially pertinent triggers of HIV-related gossip. 
The individual [would] struggle with going to the clinic to get their medication 
because they would be seen by people, and then people would be talking about them. 
I think if it was possible [to take them], with no one knowing, then that would be 
better. It is really bad here because it is not like in the suburbs where you get into your 
own yard and then there is a wall around. So here, most houses don’t have fences or walls 
around them so people see you and then they talk about you - IDI, woman, HIV status 
unknown 
 
It can affect a person, if I’m at the clinic and I’m getting medication and then people 
see me and then they then say, “I saw her at so and so place doing so and so”, then 
that might then make me stop taking my medication - IDI, woman, HIV status 
unknown 
 
Labeling through Gossip 
 
 Gossip is one way that people in the community convey the HIV status of PLHIV, 
including the status of PLHIV who choose not to disclose their HIV status to others. This 
nonconsensual disclosure in turn can lead to others in the community demonstrating avoidant 
behavior toward the individual with HIV.  
You hear people saying, “oh so and so has HIV, I don’t want to sit next to them or 
that their skin is getting worse”, so usually it’s not something that is done but rather it’s 
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what people are saying, lots of gossiping…usually you can’t tell that somebody has 
HIV, but then you can hear it from other people who tell you, when they are 
gossiping that this person has HIV - IDI, woman, unknown HIV status   
 
I have experienced [gossip] by myself. I used to like sell fried chips and meat at night, at 
the pubs. So there is this other guy, came and wanted food. [His friend] told him that he 
can’t buy food from a dead body - FG, man, living with HIV 
 
Through referring to someone as dangerous, sick, and infectious, gossip can reveal one’s HIV 
status without their consent while also spreading harmful notions about HIV.   
It was like the guy was interested [in] me. So he just took my number and said “I will call 
you, and I will see you. He didn’t call. He just asked [others], “Do you know the girl by 
the name [X] who is staying next that side”. And they said, “Hey why do you want that 
girl, she is dangerous, she is sick, she will infect you.”  [The guy] called me and said, “ 
Hey, I am afraid, people say this and that” and I just said no if you want me, or you want 
to see me, you can come and talk about that issue…the fact that you didn’t tell that 
particular person about your status, and then somebody else will tell it’s so 
demoralizing and it’s like if I am the one who is infected, it’s like to that person I am a 
liar, I am hiding something big to him/her, you know, I am a liar somehow. Because 
I didn’t have that time to say my status - IDI, woman, living with HIV 
  
The element of choice is removed when others disclose one’s status and label them as living with 
HIV through gossip. Gossip can also incorrectly imply that PLHIV are trying to hide their status, 
when in actuality a PLHIV is willing to share their status with others.  
Permanence of Gossip 
Gossip in this setting was viewed as an enduring part of social life. Many believed that 
the effects of being identified as living with HIV through gossip could have lasting effects for 
how a PLHIV views their community.  
[The community] will forget, but as a victim you will not forget, [the community] will 
definitely forget, that is why there is a Setswana saying that, the perpetrator forgets, but 
the victim doesn’t forget - IDI, woman, living with HIV 
 
[The gossip] it will be permanent, hence the Setswana saying, “a word that goes out of 
mouth never returns empty”. You must know that when somebody says something to you, 
it will be difficult for you to forget, of course the one who said it might forget - IDI, man, 




Though community members may forget the specific act(s) of gossip, it was clear from 
participants that gossip ascribed a stigmatized status to a PLHIV that was retained in the minds 
of community members, shaping interactions with that person and how they were talked about 
and thought about even after death.  
Yes, they will still isolate him/her [even after gossip stops]. Even assisting each other will 
not be the same as before. There are times when he/she would be embroiled in a fight, 
and if he/she gets hurt and bleeds, nobody will come to the rescue because they will 
say, “should you get in contact with his/her blood, you will also get infected” - IDI, 
woman, HIV status unknown 
 
[The community will] never forget. Because you find out that when someone dies, they 
will be talk that that person had HIV, even after having taken treatment for a long 
time - IDI, man, living with HIV 
 
Negative External and Internal Consequences of Gossip 
 
While gossip served as a mechanism of HIV stigma, it could also generate anticipation of 
future maltreatment and negative self-beliefs for PLHIV, and therefore foster anticipated and 
internalized stigma as well. Participants commonly discussed self/internalized stigma that 
resulted from gossip as related to stress and low self-esteem. Regardless of whether community 
members actively stigmatized PLHIV using gossip, for a PLHIV, the fear of gossip itself had 
impact as isolation was used as a strategy to avoid gossip from others.  
He says now people feel restricted with HIV because of this whole gossip thing. They 
end up isolating themselves from the community because they are afraid…they will ask 
themselves, if I engage in social gatherings once I leave people will talk bad about 
you – IDI, man, living with HIV 
 
Losing control of managing others’ knowledge of their HIV status was seen as a stressor in of 
itself associated with gossip. The social fact of gossip symbolized and could engender fear that 
many more individuals would learn or knew of a PLHIV’s status.  
It’s very difficult because a secret doesn’t stay and most of us like secretive things, we 
don’t like telling the truth. Being gossiped that you have HIV is more painful than 
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somebody just approaching you and telling you, because when they gossip, the news 
will spread more - IDI, woman, HIV status unknown 
 
Furthermore, and in consideration as to HIV treatment specifically, not adhering to HIV 
treatment as prescribed was a common problem that stemmed from gossip along with defaulting 
on one’s medication or no longer attending clinic appointments.   
Some [PLHIV] they end up leaving their medication. Some of them they don’t even 
come for their appointments because they say what will people say if they, if I go 
there they will see me, they will talk about me? Yes, they get sick. I’ve seen people 
developing…behind the ears and their legs, they swell. Some of them they change color. 
If you are white, you started becoming gray, your lips they change color because you 
don’t take your medication properly…It’s the effects of gossip or just gossip itself - 
IDI, woman, living with HIV  
 
My elder sister, she was going to take ARVs [antiretrovirals] at the clinic and then 
she started seeing people she knew and they were there, at the village and just 
talking about her, saying people were saying that they see that she takes medication, so 
she actually stopped going, she only started going back again when her health had 
become so bad that she had to go and she didn’t care anymore because she was feeling so 
sick but also that she was getting counselling at the clinic. - IDI, woman, HIV status 
unknown 
 
While individuals may have understood the dangers of not taking their medication, the social 
implications of gossip were viewed as more detrimental to wellbeing; it would be better to 
physically die rather than undergo what can be considered a social death.   
Some people they just ignore [HIV] because they fear of the gossip, people…they end 
just ignoring not going to the hospital. They are just accepting that it’s better if I die 
because even in the hospital, there is a stigma, people they still gossip. So some 
people they prefer it that way, that it is better if l die and not live again in this earth. - 
IDI, man, HIV status unknown 
 
Some [people] test themselves, but some they just leave it until they die…they don’t 
want people to know their HIV status because they know that people start gossiping, 
talking a lot of negative things about them, and again they will start looking back how 
they used to live their life…people will be talking about their past life, how they used 
to live and that they are the one who brought the condition to themselves. - IDI, 




PLHIV face myriad risks by choosing to seek clinical care to maintain their health, and this also 
meant the increased risk of others seeing them when getting medical care. Preservation of one’s 
self could become a choice between maintaining one’s social standing versus their life.  
Strategies to Mitigate Gossip and Stigma  
 
 Participants identified various ways that gossip could be mitigated and addressed in order 
to prevent poor psychosocial outcomes and treatment non-adherence among PLHIV. 
Town/village elders, village leaders, and health care workers were all seen as key individuals 
who could educate others as to the harmful effects of gossip for PLHIV. 
Social workers, they are the ones who can manage because it’s their duty. If they 
come to someone’s yard then that person will be free to talk to them, it’s not the same as 
when just a regular person does it. They are the ones that can help to bring the person 
back to normal. - IDI, man, living with HIV 
 
Tribal leaders can try, social workers, I don’t know what they are called nowadays but 
yes social workers, they can try to stop gossip. Yes, even the nearest clinic, like where I 
stay we have a clinic there, the nurses there can stop gossip, we even advise them that 
during the teachings they have at the clinics they can teach people about that. - IDI, 
man, living with HIV 
 
 
Other participants felt that instead of placing the burden of intervening solely on people in 
specific social or professional roles, it was the responsibility of everyone to prevent gossip. 
These participants felt that having key members of the community, such as elders and healthcare 
works, step in could exacerbate conflict.  
...if you have the responsibility as a parent or as a community member, having the 
responsibility, when you find there is gossip, you could intervene. - IDI, woman, living 
with HIV 
 
At the kgotlas (public meetings)…every single parent who has the responsibility in the 
community, must intervene. Then the Dikgosi (tribal chiefs) could be notified, but l 
encourage the community not to drag the issue before Dikgosi before they could 
discuss the issue amongst themselves. This could lead to a conflict, as people, you 




It is important to note that gossip was also considered to be malleable in this setting. While there 
was a perceived permanence of labels applied via gossip as discussed previously, there were 
ways participants felt that the consequences of gossip could be circumvented even when the label 
of HIV had been applied to PLHIV through gossip. Aside from individuals stepping in on behalf 
of PLHIV, a main theme that emerged was the importance of PLHIV staying healthy and 
adhering to medication to personally combat gossip and its stigmatizing effects. The ability to 
maintain one’s health and not have physical symptoms of HIV reduced the consequences of past 
gossip from others.  
It will be forgotten because I will enroll in ARV treatment, and be a glowing 
gentleman like you, you see? Then people will ultimately forget the impact that once 
happened to you. – IDI, man, unknown HIV status 
 
Self-acceptance of one’s status was also seen as a critical means of not being affected by gossip 
on a psychosocial level and of coping with HIV in general. 
I think what could be done is only when one accepts themselves. That is the only way, 
because once you have accepted yourself you wouldn’t care about [gossipers]-IDI, 
woman, living with HIV 
 
[Gossip] should not deter you if you are determined to live however you want to live. 
Yes, as long as you have accepted your status [gossip will not affect you]. - IDI, woman, 
living with HIV 
 
PLHIV could feel a sense of freedom in living with HIV given their knowledge of their own 
status. They also used this knowledge as a way to challenge those who gossiped about them.  
You will only stop gossiping when you see me glowing, adhering to my treatment, by 
then it would be you who is sick or has changed. That is when you would start 
questioning yourself on why you did that. Because I wouldn’t know if I have HIV unless 
I go for testing. I would feel like, “I know you have HIV”, while I don’t know about 
myself! Once I go to the hospital and get tested for HIV, and I am found to be 
positive, I will be ashamed, even if I don’t tell you, l will be guilt stricken. - IDI, 
man, HIV status unknown  
 
If it was me, you gossip about my status, l will say to you, “I am better, because l 
know my status, what about you”? “Do you know your status? You don’t know. You’ll 
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go before me, because you don’t know your status”. Me, I am a free person because I 




Our study elucidates gossip as a mechanism for, as well as a form of stigma, for PLHIV 
in Botswana. Important precipitators of gossip about HIV included being seen at a health clinic 
or taking medication, which could lead to subsequent labeling of a person as living with HIV and 
threaten the person’s autonomy to decide to whom, how, and when to self-disclose their positive 
status. The harmful psychosocial effects of gossip were understood to hinder testing for HIV, 
clinical care, and adherence to treatment. Nevertheless, PLHIV in this study also expressed 
myriad protective factors or coping mechanisms that could empower PLHIV to resist gossip 
and/or maintain their health despite experiencing gossip.   
In our study, the consequences of gossip were described as gendered, in line with 
previous research (8,9). Multiple studies in other sub-Saharan settings have found women to fear 
disclosing their HIV status to their partners out of fear of rejection (25). Participants in our study 
also discussed promiscuity as being attributed to women living with HIV via gossip, which is 
consistent with findings from studies that pointed to women experiencing more harmful effects 
of gossip on account of it serving to ascribe immoral behaviors to them (26). Men living with 
HIV, however, were not unaffected by gossip. Men living with HIV in various settings have 
expressed fear of gossip due to its threat to their masculinity and social standing, particularly the 
anticipated impact on their employment(8,27), which is consistent with our finding that gossip 
could limit men’s ability to fulfill their role of provider as expected in modern Setswana culture.  
Our findings also support a common sentiment observed in other studies that women are 
more likely to discuss social standing and relationships, and thus to gossip(28–30). There is even 
evidence from South Africa that women will actively choose not to have female friends to avoid 
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gossip, as it is considered to be what “women do”(31). In addition, as was this case in our study, 
prior research has found men to be adamant about not engaging in gossip (30). 
Numerous studies have identified gossip as a barrier to self-disclosure(25,32,33) . Our 
findings align with these studies as participants living with HIV in our study expressed a desire 
to conceal their status due to the potential outcome of gossip. In addition, some participants 
wanted the freedom to share their HIV status on their own terms and not have it be revealed via 
gossip, thus leading to stigma. These first two points can be informed by the Disclosure Process 
Model, which posits that negative experiences with disclosure, such as rejection and stigma, may 
lead to more concealment of one’s status in the future (34). The exclusionary practices toward 
PLHIV in Botswana is evident of gossip being used as a signal to them that they now viewed as 
“other” within their communities (35). These negative experiences include the psychosocial 
implications of gossip as expressed in this study to include stress, low self-worth, and even 
preferring to die rather than seek treatment. As suggested in our findings as well, other studies 
have also conceptualized gossip as a form of a social death sentence for PLHIV given the 
resulting ostracization (36).  
Notwithstanding, participants in this study were clear about the importance of self-
acceptance and self-disclosure as a means of coping with their HIV status as well as combating 
gossip. The act of self-disclosing to mitigate gossip has been found to be a critical strategy to 
combat stigma for PLHIV in multiple sub-Saharan African countries(37). Self-disclosing as a 
means of disrupting gossip was only one of many ways participants felt that gossip could be 
addressed, as various actors in the community were seen as key individuals to address gossip. 
Therefore, not all participants living with HIV were powerless in the face of gossip, with self-
disclosure and self-acceptance of one’s status being key forms of resilience. Positive social 
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support that enables valuing oneself and the ability to cope with an HIV diagnosis has been 
demonstrated in various studies as a core mechanism in the resistance of stigma for PLHIV(38–
40).  
The findings of this work must be considered in light of several limitations. First, 
recruitment and data collection for this study took place in a singular location, Gaborone. Despite 
the majority of Botswana’s population living within 100 kilometers of Gaborone, interpretations 
of our findings may not be reflective of the experiences of those in rural areas of the country.  
We also acknowledge that our participants tended to be older, thus this study was unable to 
equally capture the perspectives of young adults living with HIV, an age group that requires 
more attention in Botswana (6). Finally, known PLHIV who participated in our study were 
recruited from an HIV clinic. As these participants had to currently be receiving HIV care at the 
time of the study, and due to us not asking general community members about their status, we 
are missing the perspectives of PLHIV who are at different points of HIV testing and treatment 
and who are not seeking care due to factors such as stigma.  
 
Conclusion 
Our study adds to prior literature that has demonstrated stigma to be an important barrier 
to HIV care and a social determinant of mental and physical health by providing a nuanced 
examination of gossip as mechanism and form of stigma against PLHIV. Botswana has one of 
the highest rates of HIV in the world, and while the country has made critical gains in addressing 
the HIV epidemic from a biomedical perspective, HIV stigma remains common(8,9). While it is 
known that stigma is a barrier to HIV care in that it can lead to diminished quality of life, poor 
mental health, and higher mortality(2), our study emphasizes the role of gossip specifically. Our 
study is uniquely positioned to inform both the biomedical and psychosocial implications of 
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gossip for PLHIV in Botswana by eliciting both risk and protective factors for gossip about HIV. 
Critical next steps for research and practice include incorporating support for PLHIV into 
existing HIV services to specifically resist gossip and advocating for the protections of PLHIV 
from gossip through community awareness and policy change.   
 
Table 5.1. Sociodemographic Characteristics of Participants in Gaborone, Botswana 
Demographic Characteristic Full sample  
(N = 84) 
Women 
(n = 43) 
Men  
(n = 41) 
n % n % n % 
HIV status  
Living with HIV 45 53.6 24 55.8 21 51.2 
HIV status unknown 39 46.4 19 44.2 20 48.8 
Age (Mean, SD) (41.8, 13.1) (42.2, 12.5) (41.4, 14.1) 
Education  
Less than 7 years (< Form 1) 17 20.2 7 16.3 10 24.4 
More than 7 years (≥ Form 1) 54 64.3 29 67.4 25 61.0 
Unknown 13 15.5 7 16.3 6 14.6 
Employment  
Unemployed 29 34.5 20 46.5 9 22.0 
Employed or Self-Employed 43 51.2 14 32.6 29 70.7 
Retired 1 1.2 0 - 1 2.4 
Unknown 11 13.1 9 20.9 2 4.9 
Relationship status  
Married or Cohabitating 21 25.0 8 18.6 13 31.7 
Single 43 51.2 24 55.8 19 46.4 
Partnered 12 14.3 6 14.0 6 14.6 
Unknown 8 9.5 5 11.6 3 7.3 
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 Chapter 6: Discussion 
 
 The purpose of this dissertation was to consider the need for more psychosocially 
informed approaches to addressing the HIV/AIDS epidemic in SSA. There is a paucity of studies 
that examine the intersections of disclosure- whether intentional, inadvertent, or without consent- 
stigma, and mental health among both adult PLHIV and ALWH. With the majority of HIV and 
mental health research in SSA concentrated on adults, this dissertation also sought to provide an 
overview of gaps and opportunities for advancing understanding of the mental health needs of 
ALWH by taking disclosure of HIV status into greater consideration. Therefore, this dissertation: 
 
1: Conducted a scoping review that examines the relationships between mental health 
and the HIV Care Continuum for ALWH in SSA (Chapter 3) 
2: Characterized patterns of disclosure and their relationship to mental health among 
ALWH in Uganda (Chapter 4) 
3: Qualitatively assessed how gossip eliminates the choice to self-disclose one’s HIV 
status in Botswana (Chapter 5) 
6.1 Summary and Implications of Findings 
 
In Chapter 3, we examined the relationship between mental health and engagement in 
treatment across the HIV care continuum, and our main findings were that the mental health of 
ALWH was primarily assessed at the “Engaged or Retained in Care” step of the continuum in 
studies that took place prior to the implementation of Universal Test and Treat policies. More 
adolescents are acquiring HIV in SSA through horizontal transmission (1), which exacerbates the 
need for understanding the intersection of HIV and mental health during HIV testing, treatment 
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initiation, and adherence phases of care. Given observed associations between depression and 
anxiety and sustained treatment for ALWH (2,3), there are clear gaps in when adolescents are 
having their mental health assessed, let alone addressed, in the continuum. The predominance of 
cross-sectional studies in particular limits our ability to draw strong inferences about how mental 
health shapes engagement in the care continuum and vice versa, which is needed to inform 
public health efforts. For instance, the emphasis on understanding the impact of mental health on 
treatment adherence is of great importance, given that older adolescents (i.e. ages 15-19) (4,5) 
will be transitioning into adult care which requires more autonomy and self-efficacy to navigate 
their HIV treatment (6,7). The prevalence of mental health measures conceptualized in high 
income countries with limited adaptation and validation within SSA speaks to a reliance on using 
existing tools with limited attention to rigor and evaluation. While many studies do assess mental 
health broadly for ALWH in SSA, this overreliance on tools from high income settings can lead 
to spurious results (3) that further impede addressing the limited access to mental health care for 
ALWH in SSA (8–10).  
 
 Our finding in Chapter 4 that ALWH were most frequently choosing to disclose to 
nuclear family members aligns with the few studies that do exist on disclosure choices made by 
adolescents (2,11). A majority of ALWH in SSA are known to have disclosed more to family 
members then to peers and partners (2). There are mixed results from the literature stemming 
from SSA as to whether disclosing to one’s family versus others is a better decision in terms of 
one’s psychosocial wellbeing (2,12). A study from Kenya  posited that ALWH may perceive 
more stigma and discrimination from family then peers, and as such disclosure to one’s family 
was thought to have led to higher rates of depression (2). We found an association between 
depression for ALWH in Uganda (Chapter 4) who chose to self-disclose to anyone versus not 
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self-disclose their HIV status and to a brother(s) versus not to a brother. Studies from South 
Africa, Tanzania, and Zambia have found that family is the most important source from which to 
draw social support for ALWH, as fear of gossip and other forms of stigma are commonplace 
(12–14)5/24/21 10:09:00 PM.   
In Chapter 5, the exploration of gossip as stigma for adults living with HIV in Botswana 
was undertaken to better understand disclosure in all forms as a psychosocial factor important in 
the HIV epidemic response and how the concepts of disclosure and stigma may overlap in 
complex ways. Our findings make a meaningful contribution to the existing literature by 
highlighting gossip as both a marker of living with HIV and as a form of HIV stigma in of itself. 
By utilizing the What Matters Most theoretical framework to qualitatively explore the cultural 
nuances of HIV stigma, we found that participants expressed challenges related to stigma 
associated with multiple forms of disclosure: self-disclosure, inadvertent disclosure, and 
disclosure without their consent. Many described the subsequent gossip that derived from being 
seen at a clinic and how gossip about one’s status was a driver for social isolation. The fear of 
gossip from others was evident in the decision to avoid seeking clinical care for HIV and 
resisting care to circumvent a “social death” that came with others knowing one’s HIV status, a 
theme found in other studies on disclosure from SSA as well (15). Gossip is a widely attributed 
reason for PLHIV choosing not to self-disclose their HIV status and widely cited fear expressed 
by both ALWH and adults living with HIV, as gossip can threaten one’s social status (16,17). In 
our study from Botswana, the fear of gossip as stigma led to various stressors that had clear 
perceived psychosocial and mortality-related outcomes. Experiences of gossip also highlighted 




 Together, Chapters 3-5 of this dissertation contribute to the literature by demonstrating a 
need for concerted attention as to the social dynamics of HIV, particularly with regards to joint 
efforts to address disclosure, stigma, and mental health, given their overlap. For ALWH, we 
found that there was little evidence that consideration for mental health was being integrated into 
HIV treatment across critical steps in care at present, which has implications for the already 
limited youth HIV and psychosocial support services available in SSA (8,9) . We were also able 
to examine how ALWH’s choice of whom to self-disclose their HIV status to has the potential 
for differential association with mental health outcomes in our exploratory analysis. In this 
population in particular, there is a need to move beyond disclosure of parents to adolescents 
about their status and a focus on disclosure between partners to support adolescents as they gain 
autonomy in navigating their life with HIV (2). Furthermore, we were able to elucidate the 
operationalization of gossip in Botswana and how disclosure without one’s consent can be 
especially harmful to the psychosocial wellbeing of PLWH. This points to continued gaps in 
addressing the relationship between stigma and its mental health consequences for adults living 
with HIV that as a next step should be examined among ALWH, as well.  
Thus, from a life course approach, this research details psychosocial challenges that 
ALWH can experience, while making clear the need for enhanced support that remains limited 
for adults living with HIV in SSA. Overall, this work as a whole points to how the importance of 
psychosocial factors cannot be understated when it comes to living with a stigmatized health 
condition and resisting negative treatment from others across the life course. 
6.2 Limitations  
 
The findings of this dissertation should be considered in light of several limitations. First, the 
findings for Chapters 4 stem from a secondary analysis of existing data. Therefore, the findings 
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from this chapter come from a study that was not designed to answer the central aims of this 
chapter. The use of secondary data resulted in a small sample size that limits our ability to draw 
definitive conclusions from the analyses, and thus we consider these findings exploratory. Given 
differences in culture and the context of HIV treatment, generalizability to ALWH who are not 
residing in Uganda is likely limited. It is also possible that by grouping adolescents together from 
ages 10-19 in Chapter 4 (as well as in Chapter 3), done based on lack of sufficient data or 
evidence within age group for stratified analysis, these two chapters may mask significant 
heterogeneity in experiences within the adolescent developmental period.  
The qualitative study on gossip (Chapter 5) is not restricted to adolescents and mainly 
consists of individuals who are not adolescents or young adults. Therefore, the results of this aim 
are speculative as to how they can apply to a younger population. Yet, the unique emphasis on 
gossip through a theoretical assessment of stigma can inform subsequent work that considers 
gossip as a stigmatizing mechanism among AWLH. Chapter 5 also draws from a study in which 
participants were recruited from only one location and the results may not reflect PLHIV in rural 
areas of Botswana. Recruiting PLHIV who were currently engaged in care also means that the 
perspectives captured in Chapter 5 are not informative of individuals who are at different points 
in their HIV treatment.  
6.3 Implications for Future Research 
 
The results from this dissertation are suggestive of various ways in which future studies 
can advance the understanding of disclosure, stigma, and mental health in SSA. There is a 
scarcity of research looking at the relationship between mental health and HIV care for PLHIV at 
the testing, treatment initiation, adherence, and viral suppression stages of care (18,19). It is 
essential to contextualize whether mental disorders are more severe at different points along the 
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HIV Care Continuum, if mental disorders may be more or less disruptive to engaging in the care 
continuum at different points, and whether different disorders may be more prevalent at different 
continuum steps (20). It would be of further importance to couple mental health assessments 
with qualitative methods to understand specific life stressors associated with presentation of 
mental symptoms at different junctures of HIV treatment and how these stressors may be 
informed by developmental life stage.  
Research that can better inform the psychosocial factors that shape mental health and 
quality of life for PLWH at these different points of HIV treatment are also needed, given what 
we have observed around the intersection of mental health with issues of disclosure and stigma 
among adolescents and adults living with HIV in this dissertation. The reasons as to why certain 
individuals are more likely to be disclosed to versus others can enable better programs for 
supporting disclosure through engagement with specified individuals of importance (2). 
Confirming the characteristics of said individuals and how disclosure to them informs 
associations with mental health should be done among large cohorts of PLHIV to also consider 
key sociodemographic factors. Having culturally and contextually appropriate measures for this 
purpose can improve resources that promote self-disclosure. Utilizing qualitative research to 
truly understand the mechanism of different types of HIV stigma in specific settings and across 
the life course would allow for the conceptualization of culturally valid measurements to inform 
HIV stigma reduction in SSA. Measurement development more broadly in SSA is also needed 
for mental health and stigma (21). Recent work for HIV stigma in Botswana can serve as a 
model for scale development and outlines a replicable process by which other countries and 




6.4 Implications for Practice 
 
This dissertation exemplifies the need for the integration of psychosocial support that can 
address multiple, interrelated psychosocial factors into HIV treatment research, programing, and 
policy agendas in SSA.  More provider training and task sharing models for dedicated mental 
health services for PLHIV would lead to multiple sources of support to mitigate poor 
psychopathology, in a setting in which there are limited existing resources (23). Additionally, 
increasing the cadre of mental health professionals focused on ALWH and their transition to 
adult care would provide ample opportunity to reduce their risk for mental disorders during this 
critical developmental period (23,24). Increasing access to HIV peer support programs could be 
especially useful for ALWH, as there is evidence that having established peer models 
specifically to establish groups of ALWH can be fundamental to having built in social support as 
they transition to adult HIV care (25).  
Initiatives to advance the lives of PLHIV must also consider the multidimensional 
experiences of disclosure and stigma (26–28). As the 95-95-95 Goals call for the elimination of 
discrimination against PLHIV (29), there are many individual level factors that need to be 
advanced in terms of addressing the social challenges of living with HIV. Both clinic and 
community-based approaches could incorporate working with both adolescents and adults to 
identify trusted individual to whom to disclose (12,30). A built-in system within HIV treatment 
that encourages and engages with important individuals in the lives of PLHIV could lead to a 
sustained support system being put in place to help resist poor psychosocial outcomes that can 
stem from experiences of stigma (25,31). There is also a need for structural protections in place 
for PLHIV that would improve the landscape in which the legalization of punishing for non-
disclosure would be eliminated (25,32). HIV testing and counseling could be contextually 
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informed to provide newly diagnosed PLHIV with evidence-based supports to help thrive in their 
communities and remain adherent to care during a known period in which many PLHIV choose 
not to initiate care. Clinical counselling and community-based support programs, especially in 
the form of support groups for PLHIV, could be essential in instilling a sense of self-worth and 
connecting PLHIV to multiple resources for obtaining diverse forms of support (25,32)  
The journey from HIV diagnosis to viral suppression can be arduous, and at multiple 
points along this treatment continuum, individuals may stop and re-initiate care (33). 
Adolescents who were perinatally infected may also struggle to navigate adult care once they are 
expected to independently manage their treatment  (34). Disengagement in HIV treatment causes 
worse HIV prognosis and can result in multiple co-morbidities (35,36) . When PLHIV return to 
treatment, more complex and expensive clinical regimes may be required to reduce the impacts 
of the virus (37). More recognition of the utility of social support as a protective factor against 
treatment non-adherence is needed for PLHIV (36). The ways disclosure, stigma, and mental 
health are profoundly impactful in the relationship between support and treatment should be the 
next frontier of addressing the HIV epidemic.  
In summary, both separately and compounded, disclsoure, stigma and mental health are 
known psychosocial factors that place PLHIV at a higher liklihood of reduced overall quality of 
life and non-adherence to HIV treatment across the life course (28,38). Therefore, access to 
treatment alone is only a core piece of addressing the epidemic in SSA, where concentrated 
attention is needed in order to make global progress towards ending the HIV/AIDS epidemic 
(39). As health disparities and access to treatment can be driven by stigma and discrimination, 
this goal is likely not achievable without attention being paid to the psychosocial mechanisms of 
HIV (40). Accordingly, the research presented in this dissertation is grounded in the argument 
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that the end of the epidemic cannot and will not be achieved without utilization of a 
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Appendix A: Pre-UTT Study Findings 
 
Study       Key Results 
Abubakar et 
al., 2017 
• Analysis indicated a main effect of HIV status on mean BDI scores in HIV-infected (18.4 
[SD = 8.3) and HIV-affected (16.8 [SD = 7.3]) adolescents compared to the community 
controls (12.0 [SD = 7.9]), F (2, 127) = 6.704, P < .002, η2 = .095; Post hoc analysis 
showed that scores of HIV-infected adolescents were higher than those of community 
controls (P < .001) 
• HIV-affected adolescents had scores that were higher than those of the community 
controls (P = .007), but there was no difference between HIV-infected and HIV-affected 
adolescents (P = .304) 
• Results of path analytic model showed that the high scores for depression of the 
adolescents could largely be attributed to the level of cumulative psychosocial risk 
experienced; Path estimates in table 2: Maternal HIV status -> Psychosocial risk 
(Estimate:0.560; SE:0.055; Est./S.E:10.14; P: 0.000); Child HIV status -> nutritional 
status (Estimate: Estimate: 0.382; SE: 0.075; Est/SE: –5.06; P:0.000); Psychosocial risk -
> BDI score (Estimate: 0.242; SE: 0.081; Est/SE: 2.98; P: 0.003)  
• The impact of maternal HIV status was fully mediated by psychosocial risk, while the 
impact of the adolescent’s HIV status was partially mediated by psychosocial risk. 
Nutritional status did not have a significant role in predicting BDI scores 
Adeyemo et 
al., 2019 
• The lifetime prevalence of suicidal ideation was 33.3% (n = 67) while the prevalence rate 
of cur-rent suicidal ideation was 14.9% (n = 30) 
• In the regression model, having lost a family member was the only variable associated 
with current suicidal ideation (B: 1.570; SE: 0.536; WALD: 8.568; p=0.003, OR =4.807, 
95% CI 1.680-13.757 
• No statistically significant associations of lifetime suicidal ideation  
Ashaba et 
al., 2018 
• Thirty-seven participants (16%) had major depressive disorder, 30 (13%) had suicidality, 
and nine (4%) had high-risk suicidality 
•  In multivariable logistic regression models, major depressive disorder had a statistically 
significant association with bullying (AOR = 1.09; 95% CI 1.00–1.20; p = 0.04); while 
suicidality (low, moderate, high risk) had statistically significant associations with both 
bullying (AOR = 1.09; 95% CI 1.01–1.17; p = 0.02) and stigma (AOR = 1.30; 95% CI 
1.03–1.30; p = 0.02) 
Betancourt et 
al., 2014 
• Model 1 is the unadjusted model; HIV-positive: CESD-C: Model 1: 2.65 (1.72), not 
statistically significant 
• Model 2 adjusts for child age (measured continuously), gender, school attendance, 
whether the child’s mother was the primary caregiver, and socioeconomic status (SES), 
measured by a family wealth index created using items from the 2010 Rwandan 
Demographic and Health Survey; Model 2: 1.59 (1.72), not statistically significant 
• Model 3 includes additional contextual variables that could account for differences in 
child mental health: caregiver mental health, daily hardships, death of a caregiver, social 
service access, harsh punishment, and stigma, not statistically significant 
• YSR Anxiety/internalizing (*= p<0.05): Model 1: 0.13* (0.04); Model 2: 0.14* (0.04); 
Model 3: 0.02 (0.04). Odds ratios for mental health problems in HIV-positive children 
and HIV-affected children were not different at the P < .05 level of significance  
 
Bhana et al., 
2014 
• CDI - N, Mean SD range: VUKA 64 3.25 2.67 0-12; Control 58 2.34 2.35 0-11. SDQ - N, 
Mean SD range: VUKA 54 18.80 3.56 11-26; Control 47 17.68 4.34 11-32 
• Multivariate analysis: Comparison group (mean scores) - Adherence BL: 4.79; FU: 4.36; 
VUKA (mean scores) BL: 3.71, FU: 4.81, Beta: 1.527, P=0.05 
• CDI (higher worse): Comparison group: BL: 3.19, FU: 2.64; VUKA: BL: 3.31, FU: 2.03, 
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Beta: -0.736, p=0.417 
• SDQ (higher worse): Comparison group: BL: 18.80, FU: 18.38; VUKA: BL: 18.79, FU: 
16.96, Beta: -1.412, p=.371 
• SDQ (higher worse): Comparison group: BL: 18.80, FU: 18.38; VUKA: BL: 18.79, FU: 
16.96, Beta=-1.412, p=0.371 
•  
Boyes et al., 
2019 
• Depression score (M, SD): Males 1.01 (1.58), Females 1.22 (1.92); Anxiety score (M, 
SD): Males 1.93 (2.34), Females 2.36 (2.82)**, p<0.01; Posttraumatic stress score (M, 
SD): Males 4.27 (5.83), Females 5.78 (7.39)*** p<0.001; Conduct problems score (M, 
SD), Males 1.43 (1.41), Females 1.45 (1.47) 
• Associations with mental disorders: Depression, factor, B (SE), β, ***p < 0.001, **p < 
0.01., *p < 0.05.: Overall health, −0.18 (0.08), −0.06*; Internalized stigma, 0.29 (0.05), 
0.17***; Negative clinic interactions, 0.06 (0.02), 0.07** 
• (Summary of final mental health regression models (B (SE), β, ***p < 0.001, **p < 0.01., 
*p < 0.05)): Depression scores: Overall health: −0.18 (0.08), −0.06*; Side-effects 0.49 
(0.12). 0.12***; Internalised stigma 0.29 (0.05), 0.17***; negative clinic interactions 0.06 
(0.02), 0.07**; Clinic support group −0.32 (0.10), −0.09**; Past year emotional abuse 
0.56 (0.14), 0.12***; Lifetime sexual abuse 0.83 (0.25), 0.10**; Bullying victimisation 
0.04 (0.02), 0.07*; Social support −0.11 (0.02), −0.13***; positive parenting −0.04 
(0.01), −0.11***; self-efficacy −0.04 (0.02), −0.07*; age 0.07 (0.02), 0.11***; R-squared 
0.28***; Anxiety scores: Overall health −0.44 (0.12), −0.10***; side-effects 0.51 (0.17), 
0.08**; anticipated stigma 0.30 (0.08), 0.10***; internalised stigma 0.54 (0.07), 0.21***; 
clinic support group −0.43 (0.14), −0.08**; past year emotional abuse 1.17 (0.19), 
0.18***; lifetime sexual abuse 1.08 (0.34), 0.08**; Bullying victimzation 0.15 (0.02), 
0.20***; positive parenting −0.05 (0.01), −0.09**; poor parental monitoring 0.02 (.01), 
0.06*; self-efficacy −0.06 (0.02), −0.07**; poverty 0.10 (0.04), 0.07**; R-squared 
0.36***; PTSD scores: overall health −1.51 (0.31), −0.13***; mode of infection 0.93 
(0.44), 0.06*; enacted stigma 1.16 (0.39), 0.08**; internalised stigma 1.36 (0.19), 
0.20***; past year emotional abuse 1.04 (0.51), 0.06*; bullying victimisation 0.33 (0.06), 
0.16***; positive parenting −0.28 (0.04), −0.21***; age −0.28 (0.04), −0.21***; 
rural/urban −1.91 (0.43), −0.12***; r-squared 0.32***; Conduct problem scores: 
internalised stigma: 0.17 (0.04), 0.12***; past year emotional abuse 0.44 (0.12), 0.12***; 
bullying victimisation 0.05 (0.01), 0.12***; positive parenting −.04 (0.01), −0.14***; 
self-efficacy −0.08 (0.01), −0.18***; poverty −0.05 (0.02), −0.06*; age 0.07 (0.02), 
0.13***; rural/urban −0.30 (0.10), −0.08**; r-squared 0.17*** 
Casale et al., 
2019 
• Eight percent (84 adolescents) reported some level of suicidal 
thoughts over the previous month and approximately half (4%) of these 
participants indicated that they had tried to kill themselves during that 
period 
• Partial correlations between stigma, support resources, depression and suicidal thoughts 
and behaviour: ***p < 0.001, **p < 0.01., *p < 0.05: Stigma and depression (0.308⁎⁎⁎); 
stigma and suicidal thoughts or behavior (0.300⁎⁎⁎); depression and suicidal thoughts 
or behavior (0.348⁎⁎⁎); depression and social support group attendance (−0.036); 
suicidal thoughts or behavior and support group attendance (−0.020) 
• Higher HIV-related stigma is directly associated with higher depressive symptoms 
(B = 0.295; p < .001) and higher suicidal thoughts and behaviour (B = 0.185; p < .001) 
in this sample. Depression is also associated with higher suicidal thoughts and 
behaviour scores (B = 0.164; p < .001)  
Enimil et al., 
2016 
• Quantitative: (N=40), Mean (95% CI) or % (n): WHO 5 WBI Total score (scale 0-100): 
69.00 (60.02 to 77.98), 52% (21) screened positive; ICD10: Total score (0-50), 10.80 
(8.31 to 13.74), 3% (1) screened positive, 10% (4) reported at least mild depressive 
symptoms. QOL: Psychological health scale: 11.54 (11.01 to 12.09) 
• Independent samples t-tests indicated that compared to an international age-based 
normative sample, the study sample reported lower QOL on all domains, Physical 
Health (mean difference = −2.18 [95% CI = −3.13 to −1.23); Psychological Health 
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(−3.26 [−4.19 to −2.33]); Social Relationships (−1.96 [−3.04 to −0.88]); and 
Environment (−1.69 [−2.59 to−0.79]) 
• Compared to a regional sample of mixed ages, participants also reported lower QOL on 
the Physical Health (−1.98 [−3.07 to −0.89]); and the Psychological Health subscales 
(−2.36 [−3.43 to−1.29]), but not on the Social Relationships (−0.36 [−1.77 to1.05]) or 
Environment (−0.09 [−1.02 to 0.84]) subscales  
• Qualitative: Psychological Well-Being: Distress about life circumstances- Loss of family, 
food insecurity, access to education, poor treatment by family or friends 
• Distress about HIV- Worry about of the future, sadness when thinking about HIV, social 
comparisons, perceived stigma 
• Coping strategies for HIV- Avoidance of reminders, religious faith, distraction, 
empowerment, withdraw from others, cognitive reframing, hope for the future, support 
from family and friends, lack of opportunity to discuss HIV with others 
Gentz et al., 
2017 
• Poverty was associated with more total mental health difficulties, t(96)=2.63,p=.010, and 
more emotional symptoms, t(96)=3.45,p=.001, whereas better social support was a 
protective factor, particularly caregiver support (r=.337,p=.001) 
• Adherence problems, HIV-related stigma and disclosing one’s own HIV status to others 
were also associated with more total mental health difficulties 
• Poverty (b=.231,p=.023) and stigma (b=.268,p=.009) were the best predictors for total 
mental health difficulties, whereas stigma (b=.314,p=.002) predicted emotional 
symptoms 
• Social support had a protective effect on peer problems (p=.001,b=.349) 
Kim et al., 
2017 
• After adjusting for age and gender (Table 2), variables associated with non-adherence 
included negative past life experiences in the past year (experiencing household deaths 
and witnessed household violence or experienced violence), being bullied for taking 
their medicines, hospital admissions in the past year, missed clinic appointment in the 
past 6 months, depression (as measured by the CDRS-R, AOR 1.7, 95% CI [1.08–
2.70],p = 0.02), poor treatment self-efficacy and alcohol use in the past 30 days 
Li et al., 
2010 
• Adolescents’ daily lives were influenced by an 
array of factors. Unsurprisingly, they felt badly about 
being HIV positive 
• Conflict in the peer environment was a common theme, though it remains unknown 
whether this discord was related to HIV 
status, or represented a more general feature of young peoples’ communities 
• Half of participants indicated that they felt a mix of positive and negative emotions 
about the future; for example, it was common for individuals to choose both ‘‘happy’’ 
and ‘‘depressed’’ or ‘‘confident’’ and ‘‘nervous’’ when describing the future 
Louw et al., 
2016 
• Greater caregiver depression scores were significantly associated with lower perceived 
resources across all participants (R = −0.25, P < .01) 
• Caregiver depression was the only significant predictor of greater Total Problems 
scores in the full model, after controlling for age and gender (F = 8.57, df = 5.102, 
P < .01) 
• An interaction between HIV status and caregiver depression was observed (t = −2.20, 
P = .03), with follow-up within-group analyses confirming that caregiver depression 
predicted greater Total Problems scores both in HIV-negative youth (β = 0.61, 




• Quantitative: More than three quarters of the adolescents had mental health problems 
as revealed by both the Self rated SDQ (85.4%) and the Parent rated SDQ (62.5%). Of 
this number, 57.3 percent and 30.2 percent had multiple mental health problems as 
indicated by the self-rated and parent rated SDQ respectively 
• 14.6% of adolescents and 37.5% of parents reported no mental health problems; 
28.1% of adolescents and 32.3% of parents reported a single mental problem; 57.3% 
of adolescents and 30.2% of parents reported multiple mental health problems 
• Majority of the respondents (70 %) had high level of internalized stigma; majority 
(53.7%) of the respondents who had high level of stigma had multiple mental health 
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problems and only 10.5 percent who had moderate level of stigma had no mental 
health problems; there is a statistically significant relationship between level of stigma 
and presence of mental health problems (X2 = 1.123, P = 0.003) 
• Qualitative interviews with nurses: Clients who seemed to have significant mental 
health problems were referred to the psychiatric clinic for screening by the clinical 
officer psychiatry. However most of the adolescents preferred to avoid going to the 
psychiatric clinic for fear of stigma and discrimination 
• Majority of the nurses stated that there were no routine or protocols followed in the 
screening for mental health problems among adolescents 
• Almost all nurses reported that psychological care was being offered to all the clients 
during routine reviews. However, it was noted that counselling done by the 
psychosocial counsellors was the only psychotherapeutic service available for the 
adolescents living with HIV 
• The general observation was that most of the staff expressed lack of understanding of 
childhood mental health problems and hence had challenges screening and identifying 
mental health problems in the adolescents. If they suspected a child to have a mental 






• Adolescents in secondary school were five times more likely to present with better 
mental health than those who did not have any form of education (AOR 5.3, 95 % CI: 
1.86–15.41) 
• Adolescents recruited from the Northern region were less likely (AOR 0.50, 95 % CI: 
0.32–0.78) to present with better mental health than those recruited from other 
regions 
• Adolescents on ART were four time more likely to present with a better mental 
health (AOR 3.9, 95 % CI: 2.22–6.9) 
• Participants who desired to have a child in future were two times more likely (AOR 
1.7, 95 % CI: 1.05–3.00) to present with a better mental health than those who never 
intended to have children in the future 
• Adolescents who never discussed with their guardians on sexuality issues were less 
likely (AOR 0.6, 95 % CI: 0.40–0.89), to present with a better mental health 
compared to those who discussed with their guardians 
• Adolescents who had friends who smoked were less likely (AOR 0.57, 95 % CI: 
0.35–0.98) to present with a better mental health 
• Adolescents who were not satisfied with SRH services were less likely (AOR 0.34, 
95 % CI: 0.18–0.62) to present with a better mental health 
Menon et al., 
2007 
• Young people in the Zambian sample were more than twice as likely to score outside 
the normal range for the total difficulties score (odds ratio [OR] = 2.1, 95% 
confidence interval [CI]: 1.4 to 3.1) compared with the UK sample; they were also 3 
times more likely to have extreme scores for emotional symptoms (OR = 3.6, 95% 
CI: 2.5 to 5.4) and 7 times more likely to score in the abnormal range for peer 
problems (OR = 7.1, 95% CI: 4.9 to 10.2; rates of conduct disorders were comparable 
between the groups, but the Zambian sample had less than half the rates of 
hyperactivity (OR = 0.4, 95% CI: 0.2 to 0.7 
• Participants who reported that they had health problems (n = 54, 42.5%) had higher 
total SDQ-Y scores, indicating more emotional and behavioral difficulties (median = 
12.0) compared with those who did not report health problems(median = 9.0). This 
was found to be significant (z =22.027;P,0.05) 
• There was, however, no relation between WHO clinical staging and mental health 
• Univariate analyses showed no differences in continuous SDQ-Y scores between 
children who had had their HIV status disclosed and those who were unaware of their 
status; there were fewer participants in the disclosed group with extreme scores in the 




• To control for possible confounding factors, a logistic regression analysis was 
performed with emotional difficulties in the borderline or abnormal range (yes/no) as 
the dependent variable and age, gender, and disclosure status as the independent 
variables. Only disclosure status entered into the analysis, with children in the non-
disclosure group being more than twice as likely to experience concerning levels of 
emotional difficulties as those in the disclosed group (OR = 2.63, 95% CI: 1.11 to 
6.26) 
Menon et al., 
2009 
• Majority of the sample reported that they had no health problems (57.5%, N=73). 
Those who reported health problems had higher total SDQ score (median = 12.0) 
compared to those who did not report health problems (median = 9.0), this was found 
to be significant (P <0.05, Z= - 2.027) 
• Odds ratios for SDQ-Y scores in the sample of Zambian school children (n=420) 
borderline or abnormal range for the sample compared to an HIV positive Zambian 
sample (n=127) and UK sample normative sample (n=4228) 
• Total difficulties: School sample(a): 27.8% (116); UK(b):16.5% (698); HIV+(c): 
29.1% (37) a vs c OR=0.9 (0.6-1.4) c vs b OR=2.1 (1.4-3.1); Emotional Symptoms: 
school sample(a): 30.1% (126), UK(b) 11.2% (474), HIV+(c) 31.5% (40), a vs c 
OR=0.9 (0.6-1.4) c vs b OR=3.6 (2.5-5.4) 
Mutumba et 
al., 2016 
• In the multivariate model simultaneously adjusting for respondents’ socio-
demographic characteristics and psychosocial resources, psychological distress was 
associated with non-adherence (model 3: OR = 1.75 [95% CI: 1.04–2.95]). Among 
the psychosocial resources, only satisfaction with social support was significantly 
associated with non-adherence (OR = 0.42 [95% CI: 0.22–0.79]) 
• In the multivariate model simultaneously adjusting for respondents’ socio-
demographic characteristics and psychosocial resources, psychological distress was 
associated with non-adherence (model 3: OR = 1.63 [95% CI: 1.08–2.46]); among the 
psychosocial resources, frequency of praying privately (OR = 1.22 [95% CI: 1.08–
1.39]) and frequency of attending religious services (OR = 1.38 [95% CI: 1.09–1.74]) 
were significantly associated with greater odds of non-adherence, while satisfaction 
with social support (OR = 0.42 [95% CI: 0.26–0.67]) was significantly associated 
with lower odds of non-adherence to the medical regimen 
• In the multivariate model simultaneously adjusting for respondents’ socio-
demographic characteristics and psychosocial resources, psychological distress was 
associated with non-adherence (model 3: OR = 1.79 [95% CI: 1.19–2.69]); among the 
psychosocial resources, only frequency of praying privately (OR = 1.14 [95% CI: 
1.01–1.29]) was significantly associated with greater odds for non-adherence. In this 
model, frequency of attending religious services, satisfaction with social support, and 
respondents’ socio-demographic characteristics were not significantly associated with 
non-adherence to ART 
Mutumba et 
al., 2017 
• After controlling for socio-demographic variables, daily hassles (β = 0.179, 
t(462) = 3.69; p < .001), negative life events (β = 0.221, t = 5.55; p < .001), HIV-
related concerns (β = 0.323, t(462) = 7.40; p < .001), and stigma (β = 0.155, 
t(462) = 3.99; p < .001) remained statistically significant, but neighborhood insecurity 
(β =0.048 (p = .21)) and poverty-related hardships (beta=0.058 (p = .24) were not 
significantly associated with psychological distress 
• Adjusting for respondents’ socio-demographic characteristics, frequency of praying 
privately was positively associated with psychological distress (β = 0.125, 
t(462) = 3.07; p = .002), while religious coping (β = −0.173, t(462) = −4.25; p < .001), 
general coping style and behaviours (β = −0.297, t(462) = −6.79; p < .001), and 
satisfaction with social support (β = −0.222, t(462) = −4.82; p < .001) were negatively 
associated with psychological distress. However, social support (beta= −0.064 
(p = .17)) and optimism (beta= −0.067 (p = .12)) were not statistically significant in 
these analyses 
Nalukenge et • Caregivers described the causes of mental health difficulties as poverty, violence, 
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al., 2019 HIV-related disease, negligence, bereavement and effect of ART 
• Adolescents displayed a similar range of views, focusing on family illness, abuse and 
discrimination but also mentioning poverty and other social issues, in addition to 
bereavement and HIV 
• Both caregivers and adolescents described their source of knowledge to have come 
from their experiences with family members who have suffered from these mental 
health problems 
• Adolescents additionally described their source of knowledge to also include their 
personal experience 
Nduwimana 
et al., 2017 
• HIV-positive children were almost eight times more likely to live in foster families 
than unaffected children (Odds Ratio [OR] 7.88, 95 % Confidence Interval [CI] 4.45–
13.93, p <.001); however, HIV-affected children were not more likely to live in 
foster homes (OR 1.27, 95 % CI 0.64–2.50, p = .49) than unaffected children 
• HIV-positive status did not predict any family factors Positive parenting: (−.03 (−.13, 
.08), p=0.63, psychological aggression −.03 (−.09, .10), p=0.53, physical punishment 
.07 (−.03, .17), p=0.15, family unity −.05 (−.17, .06), 0.37, daily hardships .05 (−.54, 
.65), p=0.86 
• Children who were HIV-affected reported worse parenting (B = −.12 [95 % CI = 
−.22, −.02], p = .02), less family unity (B = −.12 [−.23, −.01], p = .03) and more daily 
hardships (B = .73 [.18, 1.29], p = .01) 
Ng et al., 
2015 
• Suicidal ideation (HIV+): Yes - 46 (21.10%); unadjusted OR when compared to 
HIV- and unaffected: 1.17 (0.74–1.86), not statistically significant 
• Suicidal Behavior (HIV+): Yes: 46 (21.10%); Unadjusted OR when comparted to 
HIV- and unaffected: 1.85* (1.12–3.05), statistically significant at P <0.05 
• Being HIV positive was not a statistically significant predictor of suicidal ideation: 
AOR 1.04 (0.52–2.08) p=0.91 
• Being HIV positive was not a statistically significant predictor of suicidal behavior: 
AOR: 1.80 (0.87–3.69); p=0.11 
Okawa et al., 
2018 
• Quantitative: Association between high scores of depressive symptoms and survey 
participants’ socio- demographic characteristics: unsatisfactory relationships with 
family (Adjusted Odds Ratio [AOR] 3.01; 95% Confidence Interval [CI] 1.20–7.56), 
unsatisfactory relationships with health workers (AOR 2.68; 95% CI 1.04–6.93), and 
experiencing stigma (AOR 2.99; 95% CI 1.07–8.41 
• Factors associated with non-adherence to ART: loss of mothers (AOR 3.00; 95% CI 
1.05–8.58), and lack of basic knowledge about HIV (AOR 3.25; 95% CI 1.43–7.40 
• High scores for depressive symptoms were not associated with non-adherence to 
ART AOR: 0.37 (0.13–1.01), p=0.16 
• Qualitative: psychological distress was a theme in the interviews as related to 
challenges with ART adherence 
Osok et al., 
2018 
• Findings indicated that younger age (F(2, 173) = 18.63; P < 0.001), unemployed (F 
(1, 174) = 5.49; P = 0.020), single status t(174) = 8.4; P < 0.001, living with parents 
t(174) = − 8.1; P < 0.001, higher monthly income (F (2, 173) = 3.42; P = 0.035), 
temporary housing t(174) = 4.7; P < 0.001, not receiving social support t(174) = 8.0; 
P < 0.001, ambivalent to negative reaction to pregnancy (F (2, 173) = 40.85; P 
< 0.001), having children from before t(174) = 3.7; P < 0.001, experiencing a stressful 
event t(174) = − 8.2; P < 0.001, those experiencing substance abuse t(174) = − 2.4; P 
= 0.019, not attending clinic regularly t(174) = 5.2; P < 0.001, those experiencing 
domestic violence t(174) = − 7.8; P < 0.001 and HIV positive diagnosis t(174) 
= − 4.0; P < 0.001 were significantly associated with higher depressive scores 
• After various iterations, when individual predictors using standardized beta scores 
were examined, having experienced a stressful life event (B = 3.27, P = 0.001, β 
=0.25), the absence of social support for pregnant adolescents (B = − 2.76, P = 0.008, 
β = − 0.19), being diagnosed of HIV/AIDS (B = 3.81, P = 0.004, β =0.17) and being 






• Internalized HIV stigma was directly associated with anticipated HIV stigma (β = 
.284, p < .001), depressive symptoms (β = .445, p < .001) and urban household 
location (β = -.014, p < .001) 
• Enacted HIV stigma was associated with more depressive symptoms (β = .294, p < 
.001) but not with anticipated HIV stigma 
• Abuse victimization was associated with more anticipated HIV stigma (β = .334, p < 
.001) and more depressive symptoms (β = .396, p < .001) 
Petersen et 
al., 2011 
• Worrying about who was going to care for them, loss of someone who loved them, as 
well as families fighting over them emerged as sub-themes 
• A common response of those who experienced emotional difficulties was distress at 
feeling alone in the world with the disease 
• A number of children’s family circumstances (8) did not permit them to express their 
distress because of AIDS related stigma in the family 
• Five adolescent respondents who indicated that they received little family social 
support displayed either emotional numbing or reported behavioral or emotional 
problems, including suicidal thoughts and aggressive behavior; adolescents who had 
strong family social support, appeared to cope better 
Sherr et al., 
2018 
• In multivariate models, behaviorally infected adolescents were more likely to report 
higher levels of depression (B = 0.456, p = 0.018), anxiety (B = 1.192 p < 0.001), 
internalized stigma (B = 0.41, p = 0.008), and substance use (OR = 2.99 p = 0.001) 
• Older adolescents were more likely to be treated less kindly at the clinic OR=0.88 
p<0.001), drop out of care (OR = 0.92 p = 0.004), report depression (B = 0.09 p < 
0.001), internalized stigma (B = 0.13 p < 0.001), p = 0.01), and substance use (OR = 
1.43 p < 0.001), HIV-positive adolescent girls were more likely to report suicidal 
ideation OR = 2.43 p = 0.025 
• A multivariate model of all factors and mode of infection suggests that controlling for 
socio-demographic factors and other physical, clinic-related and mental health 
experiences, behaviorally-infected adolescents are more likely to report higher rates 
of anxiety (OR1.13 p = 0.016), internalized stigma (OR = 2.85 p = 0.0010), and 
excessive substance use (OR=2.33 p= 0.011) 
Smith Fawzi 
et al., 2016 
• In bivariate analysis, nonadherence was positively associated with a number of 
psychological symptom dimensions, including irritability (self-report OR = 1.79, 
95% CI 1.06– 3.04; caregiver report OR = 1.97, 95% CI 1.22–3.18), and conduct 
problems (self-report OR = 1.79, 95% CI 1.10– 2.90; caregiver report OR = 3.35, 
95% CI 2.00–5.61) 
• Self-reported mixed anxiety/depressive symptoms were not associated with 
adherence (OR = 1.68, 95% CI 0.92–3.07); however, a positive association was 
observed through caregiver report (OR = 3.57, 95% CI 1.86–6.86) 
• Self-reported depressive symptoms were marginally associated with nonadherence 
(OR = 1.02, 95% CI 0.99–1.03), whereas caregiver report showed a significant 
relationship (OR = 1.02, 95% CI 1.01–1.04) 
• For multivariate analysis, the following relationships between mental health and 
nonadherence remained associated: conduct problems (as reported by caregiver) (OR 
= 2.90, 95% CI 1.55–5.43), and depression (as reported by caregiver) (OR = 1.02, 
95% CI 1.01–1.04) 
West et al., 
2019 
• Higher social support associated with lower depression symptomology (adjusted 
prevalence ratio 0.25, 95% CI 0.10–0.59) and lower anxiety symptomology (adjusted 
prevalence ratio 0.30, 95% CI 0.13–0.71), though no association was found with 
PTSD (adjusted prevalence ratio 0.47, 95% CI 0.06–3.49) 
Willis et al., 
2018 
• Participants attributed their experiences of depression to their relationships and 
interactions with significant people in their lives, primarily family members and 
peers 
• A sense of being different from others was common among participants, both due to 
their HIV status and the impact HIV has had on their life circumstances 
• Participants described a longing to be important or to matter to the people in their 
 
 177 
lives. A sense of isolation and rejection was common, as well as grief and loss, 
including ambiguous and anticipated loss 
• Participants’ idioms of distress included ‘thinking deeply’ (‘kufungisisa’), ‘pain’, 
darkness, ‘stress’ or a lack of hope and ambiguity for the future. Suicidal ideation 
was described, including slow suicide through poor adherence 
• Supportive factors were also relational, including the importance of supportive 
relatives and peers, clinic staff and psychosocial support programs 
Woollett et 
al., 2017 
• Females scored significantly higher for depression (p < 0.001), anxiety (p < 0.01), 
and PTSD (p < 0.001) than males. Those reporting suicidality also reported 
significantly higher suicidality on all three mental health scales suggesting that 
suicidal individuals are more likely to present with higher levels of depression (p < 
0.001), anxiety (p < 0.001), and PTSD (p < 0.001) 
• Being inappropriately touched increased the risk for being symptomatic for 
depression (RR = 2.22, p= 0.01, 95% CI), PTSD (RR = 3.08, p = 0.02, 95% CI), and 
anxiety (RR = 1.77, p =0.00, 95% CI) 
• Experiencing forced sex led to a significantly higher relative risk of experiencing 
depression (RR = 3.55, p = 0.02, 95% CI), anxiety (RR = 3.01, p = 0.01, 95% CI), 
and PTSD (RR = 2.38, p =0.04, 95% CI) 
• Experiencing peer violence at school increased the risk of experiencing PTSD (RR = 
2.56, p =0.21, 95% CI) but not depression or anxiety 
• However, experiencing peer violence outside of school increased the risk of 
experiencing depression (RR = 2.16, p = 0.01, 95% CI), anxiety (RR = 1.62, p = 
0.02, 95% CI), and PTSD (RR = 2.80, p =0.07, 95% CI) 
• Those that did not feel safe at home showed a significantly higher risk of all three 
mental health disorders – depression (RR = 5.17, p=0.00), anxiety (RR = 2.92, p 
=0.00), and PTSD (RR = 3.94, p =0.02) all 95% CI. This was similar (depression RR 
= 2.31, p =0.00; anxiety RR = 2.02, p = 0.00; PTSD RR = 3.66, p =0.01 all 95% CI) 






























      Key Results 
Coetzee et 
al., 2019 
• Proportion of participants who reported clinically significant symptoms; 24.6% (n=33) 
fatigue, 20.1% (n = 27) insomnia, 9.7% (n = 13) depression: Mean Females: 46.63 
(SD:13.89), Mean Males: 42.02 (SD 9.24), adjusted t: -2.16 p=0.03; and 6.7% (n=9) 
anxiety: Mean Females: 45.38(SD 13.84), Mean Males: 41.84 (SD 10.92), adjusted t-
score -1.59, p=0.11 
• Female participants scored significantly higher (p = <.05) on insomnia, and symptoms of 
depression compared to male participants 
• **Correlation is significant at the 0.01 level (2-tailed), *Correlation is significant at the 
0.05 level (2-tailed): age and depression = .174*; age and anxiety = 239**; fatigue and 
depression .502**; fatigue and anxiety 158; depression and insomnia .444**; depression 
and anxiety .514**; insomnia and anxiety .232 
• Depression was a predictor of fatigue: Depression B 10.904, SE 2.675 , Beta 0.311, t 
4.076, p=.000 
Enane et al., 
2019 
• Viral suppression was lowest among hospitalized adolescents (14%). Narratives 
described prominent, frequent experiences of trauma, particularly for adolescents with 
history of disengagement 
• Trauma included ordeals living with HIV – such as learning one’s HIV status after the 
death of a parent, or being hospitalized – or experiences of conflict or abuse 
• Limited social support experienced by these adolescents and families exacerbated 
trauma, resulting in isolation, disengagement from care, and even passive suicidality for 
both adolescents and caregivers 
• Mental health challenges, including isolation, depression, and alcohol abuse, were 
commonly described for adolescents and caregivers, particularly for those with history of 
disengagement; for caregivers, mental health challenges related to their own illness and 
history of trauma, deaths of loved ones, and experiences caring for a child with HIV 
• Multiple levels of stigma, interpersonal conflicts and lack of family/social support, 
resulted in serious mental health challenges 
• Suicidality and passive suicidality among caregivers and adolescents influenced 
disengagement from care 
• Despite these many difficult challenges, critical factors at the level of the adolescent and 
family supported retention. The motivation to be healthy and to receive HIV education 
were central to retention 
• Supportive family relationships were essential, and in most cases, caregivers or relatives 
were identified as primary sources of encouragement 
Kagee et al., 
2019 
• The mean converted T-score on the RCADS Depression subscale was 44.70 
(SD=12.33). The mean score was significantly lower (t=−19.05; df=133; p=0.00) than 
the threshold of 65, indicating the probability of clinically significant depression, and 
only 5.2% scored in the clinically significant range 
• The mean converted T-score on the RCADS Anxiety subscale was 43.9 (SD=12.78). 
The mean score was significantly lower (t=−19.11; df=133; p=0.00) than the threshold 
of 65, indicating the probability of clinically significant anxiety, and only 9.0% of the 
sample scored in the clinically significant range. 
• There were significant correlations between depression, insomnia (0.42); depression and 
fatigue (0.46), and between anxiety and insomnia (0.24). QOL highly and significantly 
correlated with insomnia (*0.57), depression (0.60), anxiety (0.43).  
• Regression: Anxiety (Beta 0.15, t 1.87, p=0.04) and depression (beta 0.32, t 2.03, 
p=0.00) predictors of QoL 
Kemigisha et 
al., 2019 
• The median CES DC depressive symptoms score was 13.5 (IQR: 8, 21) 
• Of the 336 adolescents, 154 (45.8%, [95% CI 40.5–51.2]) had depressive symptoms, 
meaning a CES DC score of 15 or more 
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• 42.5% of boys and 47.8% of girls had depressive symptoms 
• 37.4% of those aged 10–14 years and 62.3% of those aged 15–19 years had depressive 
symptoms 
• A total of 26 (7.7%) had thoughts of ending their own life in the last 6 months; of these, 
18 (69.2%) were female and 8 (30.8%) were male; among these, 5 were classified as 
having no current depressive symptoms (a score of <15) and 21 with depressive 
symptoms in the past two weeks (score range 20–40) 
• The odds of having depressive symptoms were 1.7 higher among adolescents who 
traveled for more than 30 min to visit the clinic compared to those who traveled for less 





















Appendix C: Interview Guide 
 
I will read you a series of statements.  For each statement, I would like you to tell me 
how you would rate your agreement or disagreement with the statement. Then, I would ask if 
you could please try to explain for what reason or reasons you rated your agreement or 
disagreement with the statement.   
Remember, we’re interested in your opinion; there are no right or wrong answers.  
1. Most people in your community would treat a person with HIV just as they would treat 
anyone. 
2. Most people in your community feel that having HIV is a sign of poor morality. 
3. Most people in your community think that a person with HIV did something to bring this 
condition on themselves. 
4. What does it mean to be a proper woman in Botswana? 
A. Does having HIV effect a proper woman’s status (in society)? 
5. Most employers in your community will hire a person with HIV if he or she is qualified 
for the job. 
6. Does gossip effect a person with HIV’s ability to be a good Batswanan? 
7. Most women/men in your community would be reluctant to date a person with HIV. 
8. When does a woman/man typically find out that they are HIV positive? 
9. Most people in your community think that resources spent treating a person with HIV 
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Psychiatry Journals: A Follow-Up Study” 
 
Five College Africa Day Panelist (Fall 2012)  
Mount Holyoke College, South Hadley, MA 
The 2012 Five College Africa Day theme was: What’s Next in African Development? Specific 
topic was undergraduate thesis analysis and how it aligned with the post Millennium 
Development Goal (MDG) era of development thinking 
 
LEAP (Learning from Experience) Panel (Fall 2012) 
Mount Holyoke College, South Hadley, MA 
Presented on a panel with three other students about research design and experience in Ghana for 
undergraduate thesis 
 
Five College Africa Day Panelist (Fall 2011) 
Hampshire College, Amherst, MA 
Presented on a panel with five students from the Five College Consortium on agriculture and 
development in sub-Saharan Africa; area of research focused on school feeding programs and 





March 2020-Present           Co-Founder and Doctoral Student Collaborator 
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Leadership and Education in Academic Research and Networking 
for Enhancing Diversity (LEARNED) Program for Minority 
Doctoral Students and Postdoctoral Fellows  
 Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD  
● Create mentorship connections for doctoral students and 
postdoctoral fellows with minority faculty  
● Host networking events across departments as well as with 
government and nonprofit organizations  
● Facilitate professional development seminars on grant writing, 
proposal development, and job talks 
 
July 2019-March 2020       Co-Founder and Co-Chair 
 Underrepresented Minority Support Network 
 Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD 
● A professional and social support network for doctoral students 
and postdoctoral fellows who self-identify as underrepresented 
minorities 
● Host Community building events within the school of public 
health and professional networking opportunities 
 
July 2019-Present            Department Representative  
Doctoral Student Council  
Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD 
● Member of Interdepartmental Programming Subcommittee 
● Advocate for the particular needs of doctoral students including 
needs related to student benefits, academic and graduation 
requirements, and funding and tuition 
● Plan and host events that foster community building among the 
degree programs 
 
Editorial Activities  





● Microsoft Office Suite 
● NVivo 
● STATA 
● Qualtrics (basic) 
● Experience with SAS and R 
Qualitative Data Analysis: 
● Semi-structured interviews 
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● Focus Groups 
● Inducive and deductive coding 
● Photovoice 
● Thematic analysis 
● Participant observation 
●  Transcribing and Coding of Interviews 
● Conceptualization and management of code books 
Quantitative Data Analysis: 
● Factor analysis and latent class analysis 
Program Management: 
● Program Evaluation 
● Grant Writing 
● Program/Project Budgeting and Management 
 
Certified in CITI Human Subjects Research 
Valid until: January 2023  
 
Additional Quantitative Coursework: 
● EPIC (Epidemiology and Population Health Summer Institute), Columbia University, 
New York, NY, Certificate of Completion of Biostatistics Course (June 2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
